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Pluripotency and self-renewal are the two distinct properties of embryonic stem cells 
(ESCs). This means that ESCs can give rise to any cell types in our bodies, including 
difficult-to-regenerate cells such as cardiomyocytes. Also, ESCs proliferate indefinitely 
in culture; they have extremely active cell cycle and exhibit a very unique cell cycle 
structure, characterized by a short Gi phase, leaving high proportion of cells in S-phase. 
In this study, the characteristics of mouse (m) ESCs were investigated. 
Iroquois homeobox gene 4 (Irx4) is a key transcriptional factor which was shown to 
play a critical role in regulating chamber-specific gene expression in the developing 
heart. Irx4 was reported to activate the expression of ventricle-specific gene and to 
suppress the expression of atrial-specific gene in a chicken heart model. Here, we 
hypothesize that overexpression of Irx4 can genetically drive mESC differentiation into 
ventricular cardiomyocytes. Lentiviral vectors harboring EF1 a-Irx4-PGK-hygromycin 
and EF 1 a-eGFP-PGK-hygromycin have been constructed and used to transduce 
mESCs. Both the /rx^-expressing and the control cell lines have been established. The 
cardiac differentiation properties of these cell lines were studied by qPCR. Preliminary 
results showed that overexpression of Irx4 would result in increased expression of 
cardiac structural genes in general. This study may help to look into the potential of 
ESC-derived cardiomyocytes for cell replacement therapy in treatment of diseases such 
vii 
as myocardial infarction. 
However, if undifferentiated ESCs are transplanted to patients, they will pose the risk 
of tumor formation. Therefore, for future therapeutic applications, it is crucial for us 
to understand the self-renewal and pluripotent properties of ESCs and to understand 
how cell cycle of ESCs is controlled. Potassium channels are one of the most diverse 
families of membrane proteins. Previous study showed that voltage-gated potassium 
(Kv) channels are present in ESCs but their role in maintaining ESC characteristics are 
unknown. Previous study in our laboratory showed that, tetraethylammonium (TEA+)， 
a Kv blocker, attenuated cell proliferation in a concentration-dependent manner. 
Possible reasons for this attenuation, including cytotoxicity, cell cycle arrest and 
differentiation, were examined. Blocking Kv did not change the viability of mESCs. 
Interestingly, KY inhibition increased the proportion of cells in GQ/GI phase and 
decreased that in S phase. This change in cell cycle distribution can be attributed to 
cell cycle arrest or differentiation. In the present investigation, loss of pluripotency as 
determined at both molecular and functional levels was detected in mESCs with Ky 
blockade, indicating that Ky inhibition in undifferentiated mESCs directs cells to 
differentiate instead of self-renew and progress through the cell cycle. Since Ky is a 
key determinant of membrane potential and that Ky blockade would lead to 
viii 
depolarization, the present results suggest that membrane potential changes may act as 
a 'switch' for ESCs to decide whether to proliferate or to differentiate: 
hyperpolarization at Gi phase would favor ESCs to enter S phase while depolarization 
would favor ESCs to differentiate. Consistent with this notion, S-phase-synchronized 
mESCs were found to be more hyperpolarized than GQ/Gi-phase-synchronized 
mESCs. Interestingly, quantitative PGR results showed that expression of Kv channel 
isoforms KYI.2, KYI.6 and BK were downregulated in GQ/Gi-synchronized cells when 
compared with that in S phase, providing potential explanation on the differences in 
membrane potential in GQ/GI phase and S phase. This study may provide new insights 
into the possible strategies of eliminating tumor formation from ESCs during 
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1.1 Embryonic Stem Cells (ESCs) 
1.1.1 What are ESCs and the characteristics of ESCs 
ESCs were first isolated from mouse in 1981 (Evans & Kaufman，1981). They were 
derived from the inner cell mass of an early embryo known as blastocyst. ESCs have 
two distinct properties, namely self-renewal and pluripotency. Self renewal property 
of ESCs allows them to divide indefinitely in undifferentiated state. While 
pluripotency refers to their ability to develop into any type of cells in the three germ 
layers including neurons from ectoderm; cardiac muscle cells and red blood cells from 
mesoderm; and pancreatic and lung cells from endoderm (Fig. 1.1). 
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Fig. 1.1 Organs derived from each germ layer, adopted from 
(http://www.ncbi.nlm.nih.gov/About/primer/genetics cell.html) 
1.1.1.1 Pluripotent markers 
A pluripotent marker is an indicator for pluripotency of a cell. Most of them are 
transcription factors involved in maintaining pluripotency (Pei, 2009). Some of the 
well-known pluripotent ESC markers are Oct-4, Sox-2 and Nanog. Loss of expression 
of these pluripotent markers implies loss of pluripotency and differentiation of ESCs 
(Hyslop et al., 2005, Hough et al., 2006). The mechanism for maintenance of 
pluripotency is complicated with the involvement of a transcriptional network 
(Chambers et al” 2003), sometimes with transcriptional factors acting as the 
2 
regulators of the others (Rodda et al., 2005). 
1.1.1.2 Germ layers' markers 
Fertilization leads to formation of zygote, which changes to blastocyst subsequently. 
This undifferentiated embryonic structure then undergoes a phase of major cell 
migration called gastrulation, producing a gastrula with three separate germ layers: 
endoderm, mesoderm, and ectoderm. The formation of the three germ layers is one of 
the first major events in specifying cell fates in the embryo (Shiraki et al., 2009). Each 
germ layer has its unique markers. For example, GATA-4 and HNF-lp were 
expressed in endoderm; Brachyury T and Mixll in mesoderm and Sox-1 in ectoderm. 
Therefore, study of germ layers' markers expression allows us to determine the fate of 
differentiation of ESCs. Several methods have been reported for directing 
differentiation of ESCs to cells of different germ layers (Boheler et al., 2002a; 
Kawasaki et al., 2000; Shiraki et al., 2009). They were determined by studying the 
expression level of different germ layer's markers. 
3 
1.1.2 Mouse ESCs (mESCs) 
1.1.2.1 mESCs co-culture with mitotically inactivated mouse embryonic 
fibroblast (MEF) feeder layers 
In order to keep mESCs undifferentiated and maintain a normal and stable karyotype 
with unlimited ability to self-renew, mESCs are usually maintained in culture by 
co-culture with MEF and/or through the addition of leukemia inhibitory factor (LIF) 
to the culture media (Burdon et al.，1999). 
1.1.2.2 Feeder free mESCs 
Some mESC lines such as D3 can maintain their self-renewal and pluripotent 
characteristics when they are cultured in the presence of LIF but in the absence of 
MEF as feeder layer (Bibel et al., 2007). These feeder free mESCs showed irregular 
colony morphology. Their appearance becomes similar to those of mESCs cultured on 
feeder after replating them on MEFs (Bibel et al., 2007). Also, feeder free mESCs can 
self-renew, express pluripotent markers like alkaline phosphatase and Oct-4 by 
immunostaining, and can differentiate into three germ layers. Taken together, these 
mESCs can maintain ESC characteristics in feeder free condition. Presence of MEFs 
in ESCs culture can sometimes interfere with experimental results. For example, it 
affects the analysis of cell cycle profile of ESCs. Therefore, feeder free mESCs 
4 
cultured in the presence of LIF are needed to be used in some of the experiments. 
1.1.3 Promising uses of ESCs and their shortcomings 
Self-renewal and pluripotent properties make ESCs promising in areas like drug 
development and toxicity test, as well as study on development and gene control and 
tissues from three germ layers for transplantation (Fig. 1.2). However, since the use of 
ESCs for research involves the destruction of blastocysts formed from 
laboratory-fertilized human eggs, people may argue that it is immoral and 
unacceptable. Besides, as ESCs are not derived from the host, they are likely to be 
rejected after transplantation. Lastly, undifferentiated ESCs can divide indefinitely, 
implying the possibility of tumor formation in transplantation therapy. 
The Promise of Stem Cell Research 




Tissues/Cells for Therapy 
I 
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Fig. 1.2 The promise of stem cell research, adopted from 
(http://stemcells.nih.gov/info/media/promise.htm). 
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1.1.4 Characteristics of ESC-derived cardiomyocytes (ESC-CMs) 
As mentioned in 1.1.1.2, methods of directing differentiation of ESCs into different 
cell types were reported (Boheler et al., 2002a). There are many reports showing the 
successful derivation of ESC-CMs (He et al., 2003; Hodgson et al., 2004; Ruber et al., 
2007; Kehat et al., 2002; Kehat et al., 2001; Kehat et al.，2004; Moore et al., 2008; 
Mummery et al.，2003; Snir et al., 2003; Xu et a l , 2002; Xue et al., 2005). 
Characterization of these ESC-CMs is usually done at molecular level, 
electrophysiological level and functional level. 
At molecular level, RT-PCR and immunostaining have been done to check for the 
cardiac specific markers expression like transcription factors GATA4, Nkx2.5 and 
structural proteins a-myosin heavy chain (a-MHC), cardiac troponin I (cTnl), cardiac 
troponin T (cTnT), atrial myosin light chain-2 (MLC-2a) and ventricular myosin light 
chain-2 (MLC-2v) (Huber et al., 2007; Kehat et al., 2002; Kehat et al., 2001; Moore et 
al., 2008; Mummery et al., 2003; Xu et a l , 2002). At electrophysiological level, whole 
cell patch clamp studies for the presence of cardiac-specific action potential (He et al., 
2003; Mummery et al., 2003), extracellular electrogram display of cardiac specific 
depolarization and repolarization processes (Kehat et al., 2002; Kehat et al., 2001; 
Kehat et al., 2004; Xue et al., 2005) and transient measurement (Kehat et al., 
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2001; Kehat et al., 2004; Mummery et al., 2003; Xue et al., 2005) have been done to 
examine the electrophysiological properties of ESC-CMs. At functional level, 
ESC-CMs have been transplanted onto freshly isolated cardiomyocytes in monolayer 
culture or injected into infarcted hearts of small animals (Kehat et al., 2004; Xue et al., 
2005). These electrically active ESC-CMs were able to integrate with and pace the 
electrical activity of ventricular cardiomyocytes both in vitro and in vivo (Kehat et al., 
2004; Xue et al., 2005). All of these findings indicate that ESC-CMs are genuine 
cardiac cells that can represent one novel source of cardiomyocytes for future cell 
replacement therapies. 
1.2 Cardiovascular diseases (CVD) 
1.2.1 Background 
CVD include coronary heart disease (heart attacks), cerebrovascular disease, raised 
blood pressure (hypertension), peripheral artery disease, rheumatic heart disease, 
congenital heart disease and heart failure. They are leading causes of death in most 
industrialized countries. In 2005, an estimated 17.5 million people died from 
cardiovascular diseases. The major causes of CVD are tobacco uses, physical 
inactivity, and unhealthy diets. The most common cause is building up of fatty 
deposits on the inner walls of the blood vessels that supply the heart or brain. The 
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blood vessels become narrower and less flexible, this is also known as atherosclerosis 
(Fig. 1.3). This makes blood vessels more likely to be blocked by blood clots. When 
this happens, the blocked vessels can no longer supply blood to the heart and brain, 
which then become damaged. When the plaque ruptures with thrombus formation in a 
coronary vessel, acute reduction of blood supply to a portion of the myocardium 
occurred. Oxygen supply can no longer meet the demand of myocardium, myocardial 
infarction (MI) results. 
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Fig. 1.3 Atherosclerosis, adopted from 
(http://www.britannica.com/EBchecked/topic-art/40935/95216A 
1.2.2 Current treatments 
MI can result in irreversible loss of millions of ventricular cell and hence permanent 
reduction in cardiac function. Current treatments for CVD include change in lifestyle, 
medication, surgery and medical devices; depends on severity of diseases. Lifestyle 
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changes include smoking cessation, healthy eating habit and regular exercises. They 
are effective preventive measures which help eliminate risk factors for CVD like 
cholesterol. Beta blockers and aspirin are the most commonly used drug for CVD 
treatment. Beta blockers work by reducing the heart rate and increasing the diastolic 
filling while aspirin works as anti-platelet drug. However, side effects were observed 
in both drugs. For patients with more serious blockages or multi-blockages, surgeries 
will be applied. Coronary angioplasty, coronary artery bypass grafting and heart 
transplant were some of the conventional therapies. However, most of the surgeries 
can only attenuate the situation, while whole heart transplant faces difficulties like 
limit in supply and immunorejection. Medical devices are sometime used together 
with surgery; this includes cardiac pacemaker and stent. Again, they cannot greatly 
improve the situation. 
(FDA, http://wvvw.fda.gov/hearthealth/treatments/treatments.html) 
1.2.3 Potential uses of ESC-CMs for basic science research and therapeutic 
purposes 
Research on ESCs and their differentiation into cardiac lineage allows better 
understanding of early process of heart development. Gene expression study could 
locate the genes that regulate heart development, their interactions and their 
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expression levels. This helps cardiologists to gain insight into cardiac-related 
researches. 
As mentioned, ESCs can be a promising source of cells for therapy due to their 
self-renewal and pluripotent characteristics. For example, ESCs can be a good source 
of cardiac cells as ESC-CMs are genuine cardiac cells showing cardiac characteristics 
at molecular, electrophysiological and functional levels. Previous reports showed that 
transplantation of these ESC-CMs into infarcted heart improve cardiac functions like 
ejection fraction and end diastolic volume compared to animals receiving 
non-cardiomyocyte derivatives (Caspi et al., 2007; Passier et al., 2008). Therefore, it 
is possible that ESCs can provide unlimited supply of cardiac cells for transplantation. 
1.2.4 Current hurdles in application of ESC-CMs for clinical uses 
As mentioned above, some recent findings suggested that electrically active 
ESC-CMs were able to integrate with and pace the electrical activity of ventricular 
cardiomyocytes in vitro and in vivo (Kehat et al., 2004; Xue et al., 2005). In addition 
to the electrophysiological integration, transplantation of ESC-CMs into infarcted 
heart could improve cardiac functions (Caspi et al., 2007; Passier et al., 2008). These 
cells survived, integrated and matured after intramyocardial injection in 
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immunodeficient mice for up to 12 weeks (van Laake et al., 2008). However, they 
were usually separated from the rodent myocardium by a layer of fibrotic tissue, 
which was secreted by the transplanted cells themselves. The presence of fibrotic 
patches, together with the transplantation of immature cells and other types of 
cardiomyocytes are major risk factors for arrhythmia. Therefore, it is suggested that 
tissue engineering approach such as employing the use of biodegradable scaffold 
together with a well-formulated mixtures of cardiovascular cells (e.g. vascular 
endothelial cells together with cardiac cells) may be tested in the future for solving the 
problem (Passier et al., 2008). Apart from this, some technical difficulties needed to 
be overcome before ESCs can be used for cell replacement therapy effectively. Firstly, 
differentiated ESCs are in heterogenous population and cardiomyocytes only 
contribute a few percentages of the whole cells population (Boheler et al., 2002a; 
Laflamme et a l , 2007). Therefore, the purity and yield of cardiomyocyte should be 
increased for therapeutic application. Secondly, immunorejection may arise during 
transplantation as ESCs are not originated from patient bodies. Solutions to overcome 
it are needed. Thirdly, tumors may form if injected cells did not terminally 
differentiate and proliferate after injection. 
In addition, current strategies of identifying cardiomyocytes present in ESC 
differentiation population are based on their spontaneous beating phenotypes (He et 
11 
al , 2003; Kehat et al., 2002; Kehat et al , 2001; Kehat et al., 2004; Moore et al., 2008; 
Mummery et al., 2003; Snir et al., 2003; Xue et al., 2005) or by the selection markers 
(e.g. fluorescence proteins or antibiotics resistance gene) driven under the control of 
cardiac specific promoters as previously mentioned (Anderson et al., 2007; Gallo et 
al., 2008; Huber et al., 2007; Xu et al., 2008). The cells obtained are mostly 
electrically active, that is, they spontaneously generate action potential even without 
stimulation, and are regarded as having action potential profiles of ‘embryonic’ nodal, 
atrial and ventricular cells (Boheler et al., 2002b; He et a l , 2003; Moore et al., 2005; 
Mummery et al., 2003). These cells are therefore having a phenotype similar to that of 
native sino-atrial nodal cells in mature heart. In addition, ultrastructural analysis and 
immunostaining of structural proteins reveals that some of the ESC-CMs have 
disorganized myofibrillar stacks, suggesting that ESC-CMs may have relatively 
immature contractile apparatus (Kehat et al., 2001; Mummery et al., 2003; Snir et al., 
2003). Although these cells may be suitable for certain clinical applications, their 
electrically active phenotype and immature contractile apparatus are certainly not 
ideal for treating patients suffered from MI because these cells may overdrive the 
electrical activity of the whole heart and therefore may not couple well with the 
contractile activity of the whole heart. This asynchronized contraction would lead to 
arrhythmias which can be lethal. It is of critical importance for the myocardial 
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infarcted heart, after cell replacement therapy with ESC-CMs, to be able to contract in 
a highly-coordinated fashion. It is therefore highly desirable to find strategies to direct 
ESC differentiation to mature ventricular cardiomyocytes, which are electrically 
quiescent until being stimulated by newly arrived action potential, for future 
therapeutic treatment of ML 
1.3 Cardiac gene markers 
1.3.1 Atrial-specific 
Atrial Natriuretic Factor (ANF) 
Atrial natriuretic factor (ANF) is a group of peptides that was originally isolated from 
the cardiac atria and has a number of important effects on blood pressure, renal 
function, and salt balance, namely the vasorelaxant, diuretic and natriuretic activities, 
respectively (Currie et al., 1983; de Bold et al., 1981). ANF has been regarded as 
naturally occurring "antihypertensive" regulators of blood pressure, volume status, 
and cardiovascular homeostasis. Previous reports suggested that at the early stage of 
development, ANF was expressed in both the atrial and ventricular cardiomyocytes. 
By in situ hybridization, ANF mRNA was first detected in a subpopulation of 
myocardial cells at embryonic day (E) 8. From E9 onwards, ANF mRNA was detected 
in the atrium and the ventricle, but its expression became atrial specific immediately 
before the time of birth (Gardner et al , 1986; Houweling et al., 2002; Small & Krieg, 
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2000; Zeller et al., 1987). 
Connexin 40 (CX40) 
Connexin 40 (CX40) is a protein component of gap junctions which are aggregations 
of intercellular channels permeable to ions and small molecules and therefore are 
important for electrical coupling between cells. CX40 is expressed in the atrial 
myocytes and is crucial for the electrical impulse conduction between atrial myocytes 
(Juang et al., 2007; Leaf et al., 2008). Mutations in both the promoter (Juang et al., 
2007) and the cDNA (Gollob et al., 2006) of CX40 was found to be associated with 
atrial fibrillation. In latter case, when mutant proteins were expressed in gap 
junction-deficient cell line, impaired intracellular transport or reduced intercellular 
electrical coupling was revealed. This is consistent with the known role of CX40 in 
the formation of gap junction (Gollob et al., 2006). 
During development, CX40 was initially expressed throughout the heart, but later 
became restricted to the atrium and the conduction system (Delorme et al., 1995; 
Marionneau et al., 2005; Small & Krieg，2004; Van Kempen et a l , 1996). Starting 
from E9 to adult, CX40 RNA was detected in the heart by in situ hybridizations (Van 
Kempen et al., 1996). On El3，CX40 was detectable in atria and ventricles; as 
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development proceeded, the CX40 distribution pattern in the atria was maintained, 
whereas a more dynamic pattern was observed in the ventricles (Delorme et al., 1995). 
There was a temporal disappearance of CX40 mRNA from the fetal ventricles during 
development. In adult myocardium, CX40 was expressed in atrial cardiomyocytes but 
not in ventricular cardiomyocytes (Gourdie et al., 1993; Gros et al., 1994; Marionneau 
et al., 2005; van Kempen et al., 1995). 
Hairy-related transcription factor 1 (HRTl) (also named as HEYl, HESRl, 
GRLl, HERPl) 
Hairy-related transcription factors (HRT), including HRTl and HRT2, are basic 
helix-loop-helix transcriptional repressors (Kokubo et al., 2005a). HRTl was found to 
be expressed in atrial cardiomyocytes, but not in ventricular cardiomyocytes (Fischer 
& Gessler, 2003; Kokubo et al., 2007; Nakagawa et al., 1999). 
Forced expression of HRTl in the entire cardiac lineage of mouse resulted in reduction 
or loss of the atrioventricular (AV) canal, indicating the importance of HRTl AV canal 
formation (Kokubo et al., 2007). Consistently, in these HRT 1 -misexpressing hearts, 
expression levels of bone morphogenetic protein 2 (BMP2) (Kokubo et al., 2007; 
Rutenberg et al.，2006) and T-box transcription factor (TBX) 2 (TBX2) (Kokubo et al., 
2007) were significantly reduced; since BMP2 and TBX2 are AV canal-specific genes, 
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HRTl is thought to be important for the precise formation of the heart's AV boundary. 
It is known that Notch signaling is required for multiple aspects of cardiovascular 
development (High & Epstein, 2008; Niessen & Karsan, 2008). Notch 1-activation in 
the mesodermal lineage led to myocardium abnormality. Also, in Notch 1-activated 
heart, HRTl was strongly induced in both the ventricle and the AV canal. Interestingly, 
this myocardium abnormality could be rescued by the knockout of HRTl gene from 
these Notch 1-activated hearts (Watanabe et al., 2006). This study indicated that HRTl 
was the downstream target of Notch 1 signaling and that no/low expression of HRTl in 
ventricle was important for proper differentiation and functioning of the heart. 
Similarly, misactivation or inhibition of Notch2 specifically induced or inhibited 
HRTl, respectively, suggesting HRTl was the direct mediator of Notch2 (Rutenberg 
et al., 2006). There were conflicting results which showed that expression of HRTl 
and HRT2 were independent of Notch2 signaling (Kokubo et al., 2007). On the other 
hand, some studies suggested that mouse HRTl and HRT2 genes were redundantly 
required to mediate Notch signaling in the developing cardiovascular system (Kokubo 
et al., 2005b; Kokubo et al., 2007). In vitro studies have revealed that the Notch 
signaling pathway directly regulated transcription of both HRTl and HRT2 (Xiang et 
al., 2006). 
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Atrial myosin light chain 2 (MLC-2a) 
Atrial myosin light chain 2 (MCL-2a) is a structural protein that is responsible for 
cardiac sarcomere formation and therefore is important for the contractile function of 
cardiac cells, particularly the atrial cardiomyocytes. 
During development, in contrast to ventricular myosin light chain (MLC-2v), which 
was found to be ventricular-specific from the onset of expression, MLC-2a was 
initially expressed throughout the linear heart tube at around E7. Its expression was 
higher in atrium than ventricle starting from E9; restricted expression in solely atrial 
cardiomyocytes was detected at later stage of development (Hailstones et al., 1992; 
Kubalak et al., 1994), starting at around El2. Similarly, in vitro study using 
differentiating ESCs showed that the MLC-2a gene was differentially regulated when 
compared with MLC-2v gene, with MLC-2a transcripts detectable from day 6 in 
suspension cultures as compared with day 9 for MLC-2v (Kubalak et al., 1994). This 
suggested that atrial expression of MLC-2a was achieved through inhibition of 
expression of MLC-2a transcription in the ventricle. Similarly, this inhibition of 
expression in ventricle was also found for other atrial-specific genes such as ANF (see 
below). In adult heart, MLC-2a expression was restricted to atrium, and was not 
detectable in ventricle (Kubalak et al., 1994; Marioiineau et a l , 2005). 
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Sarcolipin 
Sarcolipin is a 31 amino acid integral membrane protein. It is a calcium binding 
protein which is an endogenous regulator of calcium cycling. It interacts with and 
inhibits sarco(endo)plasmic reticulum calcium adenosine triphosphatase (SERCA) by 
lowering its apparent calcium affinity and reducing its Vmax (Asahi et al., 2002). The 
cardiac isoform of SERCA (SERCA2a) plays an important role in the contraction and 
relaxation of cardiac muscle. Sarcolipin inhibits the cardiac SERCA2a and thereby 
decreases sarcoplasmic reticulum (SR) calcium transport function (Asahi et al., 2004; 
Babu et al., 2006). 
Ablation of sarcolipin enhanced Ca^ "^  transport and atrial contractibility (Babu et al., 
2007b) while overexpression of sarcolipin decreased apparent affinity of SERCA2a 
for calcium, impaired cardiac contractility and caused mild progression to cardiac 
hypertrophy (Asahi et al., 2004; Babu et al., 2006). In addition, sarcolipin was shown 
to bind directly to phospholamban (Asahi et al., 2002; Babu et al., 2005), inhibiting 
the formation of phospholamban pentamers and therefore elevating the content of 
phospholamban monomers (the active form). This accounted for the superinhibitory 
effects of sarcolipin in the presence of phospholamban on SERCA (Asahi et al., 
2002). 
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Taken together, sarcolipin inhibits SERCA by its direct interaction with SERCA or 
through stabilization of the SERCA-phospholamban complex. Because the activity of 
SERCA2a is important for the intracellular calcium distribution and is a determinant 
of the cardiac action potential, sarcolipin plays an important role in heart physiology. 
Expression of sarcolipin mRNA was most abundant in the atria and was undetectable 
in the ventricles in different species studied (Minamisawa et al., 2003; Vangheluwe et 
al., 2005). Interestingly, unlike most other atrial-restricted genes, sarcolipin was 
atrial-specific from the onset of its expression at around El 1.5 to El2.5 and increased 
abruptly at around El6.5 (Minamisawa et al., 2003; Small & Krieg，2004). Expression 
of sarcolipin increased over time in the atria but was undetected in the ventricles at 
any of the developmental stages (Minamisawa et al., 2003; Small & Krieg, 2004). In 
the adult stage, sarcolipin was still expressed exclusively in the atrium (Babu et al., 
2007a; Minamisawa et al., 2003; Vangheluwe et al., 2005) 
1.3.2 Ventricular-specific 
Iroquois homeobox gene 4 {Irx4) 
Irx4 is a member of the Iroquois family of homeobox transcription factors. Previous 
studies showed that Irx4 plays a critical role in establishing chamber-specific gene 
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expression in the developing heart (Bao et al., 1999; Bruneau et al., 2000). Irx4 has a 
ventricle-restricted expression pattern at all stages of chick, rat and mouse heart 
development, beginning at stage when ventricular progenitor starts to appear (Bao et 
al., 1999; Bruneau et al., 2000; He et al., 2008). 
Interestingly, Irx4 protein was shown to regulate the chamber-specific gene expression 
by activating the expression of the ventricle-specific gene and suppressing the 
expression of the atrial-specific gene: overexpression of Irx4 led to a down-regulation 
of atrial-specific gene atrial myosin heavy chain-1 (AMHC-1 in chick) and an 
upregulation of ventricular-specific gene ventricle myosin heavy chain-1 (VMHC-1 in 
chick) in atria; whereas knockdown of Irx4 led to an upregulation of AMHC-1 and a 
down-regulation of VMHC-1 in ventricles (Bao et al., 1999). 
Irx4 was reported to be downregulated in NKX2.5 or dHAND single mutants 
(Bruneau et al., 2000). In NKX2.5-/- dHand-/- double mutants, ventricular dysgenesis 
occurred and there was a complete abolishment of the Irx4 (Yamagishi et al., 2001). 
This suggested that both NKX2.5 and dHAND cooperatively regulated the expression 
of Irx4. However, it is at present unknown whether NKX2.5 and dHand act 
independently or synergistically to activate Irx4. Bioinformatics and promoter 
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analysis techniques are required to allow us to have further insights into this. 
Previous report showed that mice lacking retinoic X receptor a (RXRa) or myocyte 
enhancing factor (MEF) 2C had normal Irx4 expression, although another study 
showed that there was a delayed and decreased Irx4 expression in the MEF2C-/-
embryo (Vong et al., 2006). Nevertheless, this indicated that RXRa and MEF2C were 
probably not required for Irx4 expression. 
Concerning the downstream targets of Irx4, Irx4 inhibited the expression of atrial 
specific gene AMHCl (chick homolog of quail slow MyHC3) within developing 
ventricles in chick as mentioned previously (Wang et al., 2001). Irx4 did not bind 
directly to the vitamin D response element (VDRE) in the AMHCl promoter, unlike 
that of vitamin D receptor (VDR) and RXRa. Instead, Irx4 inhibited AMHCl 
expression in the ventricles by interacting with the RXRK. component of the 
VDR/RXRfic. heterodimer and forming an inhibitory protein complex composed of 
VDR, RXRa, and Irx4. This inhibitory complex in turn bound at the VDRE and 
decreased AMHCl expression in ventricle (therefore, AMHCl was expressed only in 
atrium) (Wang et al., 2001). 
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Another cardiac transcription factor, Inc5, was found to repress the expression of 
potassium channel, Kcnd2 (Kv4.2) (Costantini et al., 2005). Interestingly, combined 
loss of Irx5 and Irx4 disrupted ventricular repolarization with a predisposition to 
arrhythmias. On the other hand, increase in Irx5 and Irx4 protein levels was associated 
with a decrease in Kcnd2 expression. These suggested that Irx4 and Irx5 functioned in 
a cooperative way (He et al., 2008) to affect conductivity by controlling the 
expression of potassium channels. 
Altogether, Irx4 affects the expression of AMHCl and VMHCl and cooperates with 
Irx5 to influence the expression of Kcnd2. Until now, the direct target(s) that can be 
transcriptionally controlled by Irx4 have not yet been identified. 
Hairy-related transcription factor 2 (HRT2) (also named as HEY2，HESR2, 
CHFl, GRL2, HERP2) 
HRT2 is a basic helix-loop-helix transcriptional repressor. It was found to be 
expressed in ventricular cardiomyocytes, but not in atrial cardiomyocytes, as oppose 
to HRTl described above (Fischer & Gessler, 2003; Koibuchi & Chin, 2007; Kokubo 
et al., 2007; Nakagawa et al., 1999; Xin et al., 2007). 
Mice homozygous for a null mutation of HRT2 died perinatally (Xiang et al., 2006) 
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with a spectrum of cardiac malformations including dilated left ventricular chamber 
(Xiang et al., 2006), markedly diminished fractional shortening of the left ventricle 
(Kokubo et al., 2004; Sakata et al., 2002; Xiang et al., 2006), abnormal ventricular 
septation (Sakata et al., 2002) and AV valve formation (Kokubo et al., 2004). In 
addition, conditional knockout of HRT2 specifically in cardiomyocytes resulted in 
ectopic activation of atrial genes in ventricular myocardium with an associated 
impairment of cardiac contractility. In contrast, forced expression of HRT2 in atrial 
cardiomyocytes repressed atrial specific gene expression (Kathiriya et al., 2004; Xin 
et al., 2007). 
Similar to HRTl, forced expression of HRT2 in mouse heart led to reduction or loss of 
AV canal, suggesting the critical role of HRT2 in AV canal formation (Kokubo et al., 
2007). Interestingly, transgenic mice that overexpress HRT2 in the myocardium 
showed an attenuation of hypertrophic response in response to a-adrenergic 
stimulation, suggesting that HRT2 functioned as an antihypertrophic gene (Xiang et 
a l , 2006). 
All these studies suggested that HRT2 is important for mammalian cardiac 
development, especially in left ventricular development by suppressing atrial identity 
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(Koibuchi & Chin, 2007; Xin et al., 2007). It is also important for maintaining the 
normal myocardial contractility (Kokubo et al., 2004; Sakata et al., 2002; Xin et al., 
2007). 
As mentioned previously, Notch signaling pathway was found to directly regulate 
transcriptions of both HRTl and HRT2 (Xiang et al., 2006) which worked redundantly 
to mediate Notch signaling (Kokubo et al., 2005b; Kokubo et al., 2007). 
KvLQTl (KCNQl) regulator B-subunit MinK (KCNEl) 
Cardiac action potential is composed of several different phases in which the 
repolarization phase is dependent on the transmembrane delayed-rectifier cardiac 
potassium current. This potassium current consists of the slow (IKs) and fast (IKr) 
components generated by the pore-forming a-subunits KCNQl and KCNH2, 
respectively, in association with their regulatory p-subunits. MinK, encoded by 
KCNEl, is a single transmembrane domain ancillary subunit for recapitulation of the 
IKs current. MinK was reported to associate with the KCNQl in the ventricles of 
mammals including guinea-pig, mouse and human (Abbott et al.，2007; Marionneau et 
al., 2005). MinK-KCNQl channels generated the IKs current which contributed to 
human ventricular repolarization in which MinK functioned to regulate the kinetics of 
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KCNQl (e.g. MinK slowed KCNQl activation, removed inactivation, increased 
unitary conductance and was responsible for the pharmacology of the complex) 
(Barhanin et al., 1996; Finley et al., 2002; Sanguinetti et al., 1996; Sesti & Goldstein, 
1998). Interestingly, mutations in MinK were found to be associated with human long 
QT syndrome (Wang et al., 1996). 
Previous study showed that, during mouse heart development, KCNEl expression was 
first observed at E9.5 throughout the entire myocardium. Progressively, at El6.5, 
KCNEl expression was mainly confined to the compact ventricular myocardium 
(Franco et al., 2001). This was in contrast to the expression pattern of potassium 
channel a-subunits such as KCNQl and KCNH2 which were expressed first at E9.5 
and showed comparable levels of expression within the atrial and ventricular 
myocardium during the embryonic and fetal stages (Franco et al., 2001). In 
10-week-old mice, KCNEl was expressed preferentially at low level in the ventricle 
of an adult heart but remained undetectable in the atrium (Marionneau et al., 2005). In 
contrast, the expression patterns in normal human heart seems to be of significant 
differences (Ordog et a l , 2006). Some studies showed that mRNA of KCNEl was 
present in the atrium of healthy human myocardium (Lundquist et al., 2005; Ordog et 
al., 2006). 
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Ventricular myosin-light chain 2 (MLC-2v) 
MCL-2v is a structural protein that is responsible for cardiac sarcomere formation and 
therefore is important for the contractile function of cardiac cells, particularly the 
ventricular cardiomyocytes. It was also found to be crucial for heart development 
(Seguchi et al., 2007). MLC-2v is ventricular specific at all times during development 
(Marionneau et al., 2005; Nguyen-Tran et al., 1999; O'Brien et al., 1993). Interestingly, 
MCL-2v knockout mice survived until E12.5. Although MLC-2a protein was found to 
express in the mutant ventricles, ultrastructural analysis revealed defects in sarcomeric 
assembly. Besides, an embryonic form of dilated cardiomyopathy characterized by a 
significantly reduced left ventricular contractility was detected (Chen et al., 1998)， 
suggesting that MCL-2v had a unique function in the maintenance of ventricular 
contractility. In fact, MLC-2v isoform was found to contribute to the greater 
power-generating capability of ventricle compared with atrium (Buck et al., 1999; 
Pawloski-Dahm et al., 1998). 
During development, MLC-2v mRNA was found in the ventricular region at E8 by in 
situ hybridization. Its expression was high in the ventricular portion of the heart tube, 
but was not detected in the atrial or sinus venosus regions. Minimal level of MLC-2v 
mRNA was also found in the proximal outflow tract of the heart tube at this time. By 
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E9-10, MLC-2v mRNA displayed a temporally and spatially distinct expression 
pattern in the proximal outflow tract region adjacent to the ventricular segment. By 
E l l , prior to the completion of septation, its expression became restricted to the 
ventricular region at and below the level of the atrioventricular cushion (O'Brien et al., 
1993). Similarly, in vitro study using differentiating ESCs also suggested the 
expression of MLC-2v from day 9 of suspension culture, a time later than the 
expression ofMLC-2a (Kubalak et al , 1994). 
1.4 Lentiviral vector-mediated gene transfer 
Lentivirus (LV) is a gene delivery tool of an expression cassette which made up of 
one or more genes and their regulatory sequences to target cells. The transgene 
expression is stable in both dividing and non-dividing cells, either in vitro or in 
several organs in vivo (Hong et al , 2007; Naldini et al., 1996). For safety reasons 
lentiviral vectors never carry the genes required for their replication. To produce a LV, 
several plasmids are required: packaging plasmids for encoding viron proteins and 
plasmid containing the target gene to be delivered. They are transfected into a 
packaging cell line, commonly HEK 293. 
Lentiviral vectors have a number of advantages for gene targeting over other retroviral 
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vectors. Firstly, LVs can transduce both mitotically active and inactive cells such as 
hESCs (Zhou et al., 2007). Secondly, transgenes carried by LVs are less likely to be 
silenced after integration into host genome (Blomer et al., 1997; Kafri et al., 1997; 
Lois et al., 2002; Naldini et al., 1996). Third, as mentioned, LVs does not contain viral 
gene for replication. The transgene expression is solely controlled by an internally 
built promoter. Fourth, LVs can better accommodate multiple promoters, which are 
either ubiquitous or cell-specific (Hong et al., 2007). Fifth, it allows permanent gene 
expression. 
Since the site of integration into genome is random, it may disturb cellular genes 
expression and lead to activation of oncogenes promoting the development of cancer 
(Montini et al., 2006). This is the major concern for possible applications of LVs in 
gene therapy. However, studies have shown that lentiviral vectors have a lower 
tendency to integrate in places that potentially cause cancer than gamma-retroviral 
vectors (Cattoglio et al., 2007). Another study even found specifically that lentiviral 
vectors did not cause either an increase in tumor incidence or an earlier onset of 
tumors in a mouse strain with a much higher incidence of tumor formation (Montini et 
al., 2006). As a matter of fact, clinical trials that utilized lentiviral vectors in gene 
therapy for the treatment of HIV experienced no increase in oncologic events so far 
(Montini et al., 2006). 
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1.5 Cell cycle in ESCs 
1.5.1 Cell cycle 
Cell cycle is the series of events that take place in a cell leading to its division and 
replication. It consists of five distinct phases: Go phase (quiescent), Gi phase (gap 
1), S phase (synthesis), G2 phase (gap 2) and M phase (mitosis) (Fig. 1.4). 
Cell cycle is tightly regulated to ensure it is correct and ordered and at the same time 
prevent uncontrolled events. There are two key regulators in cell cycle: cyclins 
(regulatory subunits) and cyclin-dependent kinases (cdks，catalytic subunits). When 
they associate, CDKs will be activated and then phosphorylate the downstream target 
proteins for cell cycle progression. CDK levels remain constant throughout the cell 
cycle, while cyclins are unstable proteins that are synthesized and degraded at precise 
times during the cell cycle, thus generating waves of CDK activity (White & Dalton, 
2005). In fact, the precise timing of cyclin accumulation is a critical factor in cell 
cycle progression (Resnitzky et al., 1994). Cyclin protein levels are regulated by 
transcriptional mechanisms and at the level of protein stability (White & Dalton, 
2005). Apart from this, the cell cycle progression also depends on other factors like 
growth factors, cell-cell contact, cell density and nutrient availability (White & Dalton, 
2005). 
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Fig. 1.4 Events occur at different phases of the cell cycle, adopted from 
rhttp://www.le.ac.uk/ge/genie/vgec/sc/cellcvcle.htmn 
1.5.2 Characteristics of cell cycle in ESCs 
ESCs are known to have unusual cell cycle when compared with other somatic cells 
(Fujii-Yamamoto et al., 2005, Jirmanova et al., 2002, Kapur et al., 2007). ESCs have a 
very short Gi-phase, meaning that ESCs reenter the S-phase very shortly after exit 
from M-phase. And ESCs spend nearly half of time in S-phase before entering the G2 
phase. Interestingly, at the molecular level, in contrast to other somatic cells in which 
there are rhythmic rise and fall of the expression of cyclin E, A and B as well as 
activities of cyclin-dependent kinases (cdks) as cells progress through the cell cycle, 
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most of these cell cycle regulators such as cyclin E, cyclin A and the cdks such as 
cdk-2 are present at relatively stable level throughout the cell cycle in ESCs 
(Fujii-Yamamoto et al., 2005) except cyclin B/cdkl (Stead et al., 2002). In addition, 
ESCs express low level of cyclin D1 and no cyclin D2 and cyclin D3, and lack cdk-4 
activities (Jirmanova et al., 2002). When compared with somatic cells, cyclin A2 and 
cyclin B1 are extremely abundant in undifferentiated ESCs. Upon differentiation, 
cyclin A2 and cyclin B1 are rapidly downregulated (Fujii-Yamamoto et al., 2005) 
while there is a dramatic increase in cyclin D level (Jirmanova et al., 2002) 
1.6 Potassium (K+) channels 
Potassium channels are widely distributed and found virtually in all living organisms. 
They are tetrameric in nature with distinctive pore-loop structure that lines the top of 
the pore and is responsible for potassium selective permeability. There are over 
80 mammalian genes that encode potassium channel subunits. 
There are four major types of potassium channels: Voltage-gated potassium (Ky) 
channels, calcium-activated K+ (Kca) channels, inward-rectifying K+ (KIR) channels 
and two-pore K+ (K2p) channels. These four classes differ in structures and functions. 
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1.6.1 Voltage gated potassium (Ky) channels 
Kv channels are potassium channels that sensitive to voltage changes in the membrane 
potential. They are tetrameric in nature, either in form of homo- or hetero-tetramers. 
Each subunit consists of six membrane spanning hydrophobic a-helical sequences. 
There are 12 subclasses of Ky channel subunits (Gutman et al., 2005). Alpha subunits 
form the actual conductance pore. While beta subunits are auxiliary proteins which 
associate with alpha subunits in a a4p4 stoichiometry (Pongs et al., 1999). These 
subunits modulate the activity of Kv channels (Li et al., 2006). Together, Ky channels 
are extremely diverse due to hetero-multimerization. Alternative mRNA splicing and 
post-translational modification also contributes to the diversity of Kv channels. 
1.6.2 Role of Kv channels in maintenance of membrane potential 
Kv channels act as the main determinant of membrane potential (Parihar et al , 2003). 
At resting state, the membrane potential of a cell is more negative inside relative to 
that of outside. On the other hand, intracellular K+ concentration is higher than the 
extracellular one. As the charge difference is greater than that of potential difference, 
opening of Ky channels at resting state will lead to efflux of K+ down the 
electrochemical gradient, making the membrane potential more negative than the 
resting membrane potential (hyperpolarization). On the other hand, inhibition of Kv 
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channels (by application of Kv channels blockers such as tetraethylammonium) will 
make the membrane potential more positive than the resting membrane potential 
(depolarize). Ky channels are shown to play a major role in cell proliferation in both 
normal and tumor cells (Parihar et al., 2003). It was suggested that K+ channels are 
required for cell cycle progression, in particular, the initiation of Gi progression 
(Wonderlin & Strobl, 1996). 
1.7 Objectives and significances 
The first objective of the project is to investigate the effect of overexpression of Irx4 
on the cardiac differentiation of mESCs. MESCs were transduced with Irx4 by 
LV-mediated gene transfer. Differentiation of transduced mESCs was done which was 
followed by cardiac gene expression study by qPCR. Expression of cardiac structural 
genes, atrial-specific genes and ventricular-specific genes were studied in order to 
have a more complete picture on the effect of overexpression of Irx4 in cardiac 
differentiation. 
Another objective of the project is to understand the role of Ky channels in the fate 
determination of ESCs. MESCs were treated with Ky channel blocker TEA+ and the 
fate (apoptosis, differentiation) of mESCs was determined at molecular and functional 
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levels. Membrane potential and expression of Ky channel isoforms at different phases 
of cell cycle were also studied to investigate the changes occurred during cell cycle 
progression. 
This project may provide insights into the potential strategies of increasing the yield 
of cardiomyocytes differentiated from ESCs or help scientists to seek for the new 
sources of cardiomyocytes for therapeutic uses. On the other hand, the study of the 
role of Kv channels in ESCs may provide strategies of preventing tumor formation due 
to undesired growth of ESCs that are not terminally differentiated and help us 
understand more about the basic biology of ESCs. 
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Chapter 2 
2. Materials and methods 
2.1 Mouse embryonic fibroblast (MEF) culture 
2.1.1 Derivation of MEF 
CD-I strain mouse at 13 to 14 days gestation was chosen. Cervical dislodgement was 
performed to sacrifice mouse. After that, the mouse was sprayed with alcohol and 
placed inside sterile primary culture hood with their belly up on an absorbent paper. 
Mouse abdomen was saturated with alcohol pad and cut open to expose the 
peritoneum by sterilized instruments. Instruments were resterilized by alcohol bath 
and Bunsen burner every time after use. Then, peritoneal wall was cut opened to 
expose uterine horns, which were then removed and placed into a sterile petri dish. 
They were washed three times with 10ml PBS afterward. Subsequently, embryonic 
sacs were cut opened with watchmaker's forceps and scissors to release embryos 
which were transferred to a new Petri dish where they were washed three times with 
10 ml PBS. The number of embryos was counted and recorded. In the Petri dish 
containing PBS, visceral tissue which is in darker color was separated from the 
embryos. Cleared embryos were put on a fresh plate while visceral tissue was left 
behind. Again, the embryos were washed three times with 10 ml PBS. Excess PBS 
was removed by serological pipette and the embryo tissues were minced with curved 
35 
dissecting scissors for approximately 5-10 minutes into grain sized pieces. After that, 
2ml trypsin was added and tissues were minced for additional few minutes until sizes 
of the pieces are further reduced. 5 ml trypsin was added again and the cells were 
0 
vigorously pipetted up and down. Afterwards, the dish was placed into 37 C 
incubator for 30 minutes. After incubation, the cells were pipetted vigorously up and 
down until it has a sludgy consistency. At this time, MEF culture media containing 
Dulbecco's modified Eagle's minimal essential medium (DMEM; Hyclone), 
supplemented with 10% heat-inactivated (57�C, 30 minutes) fetal bovine serum (FBS; 
Hyclone), 2 mM L-glutamine (Gibco), 1% (v/v) non-essential amino acid solution 
(Gibco) and 1% (v/v) penicillin / streptomycin solution (PS; Gibco) was added and 
0 
the mixture would be distributed to T75 culture flasks and incubate at 37 C overnight. 
The number of T75 flasks required equals to the number of embryos recovered 
divided by three. 
Next day, the primary cultures were viewed under microscope to determine the 
confluency of MEF. When there was more than 90% confluent, the cells would be 
harvested. For stock keeping, cells were frozen in 10% DMSO/ DMEM medium at 
0 
-80 C overnight and transferred to liquid nitrogen for long term storage. 
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2.1.2 MEF culture 
Frozen stock vial was removed from liquid nitrogen. The vial was then immersed in a 
0 
37 C water bath with the cap did not submerge until only a ball-like crystal remained. 
Cells were transferred into a 50ml falcon with 2ml pipette gently. Immediately after, 
10ml of MEF culture media was added to cells drop-wisely to dilute the DMSO in the 
o 
cryopreservation media. Afterwards, cells were centrifuged at lOOOrpm, 4 C for 5 
minutes to remove cryoprotectant from cell culture and the cell pellet was 
resuspended in 10 ml MEF culture media and transferred to T75 flask. The flask was 
o 
incubated at 37 C with 5% CO^ supply. Cell density was monitored daily and cells 
were passed at 1:3 to 1:4 ratio weekly to passage. 
2.1.3 Irradiation of MEF 
To harvest cells, MEF media was aspirated from the T75 flask. The flask surface was 
washed with 5 ml PBS and then aspirated. 4ml trypsin- EDTA solution was added and 
0 
the cells were incubated at 37 C for 3-5 minutes to dislodge cells. 5 ml MEF culture 
media was added to neutralize trypsin reaction. A cell suspension was formed by 
mixing the dislodged cells and MEF culture media with a 10 ml serological pipet and 
all cells were then pooled into a 50ml falcon. Supernatant solution was removed by 
0 
centrifugation at lOOOrpm, 4 C for 5 minutes. Cell count was performed after 
37 
resuspension. Cells required to plate for use was reconstituted to 20ml cell suspension 
and irradiated by gamma irradiation at 7000-8000 rads. Irradiated cells were 
0 
transferred on ice and centrifuge at lOOOrpm, 4 C for 5 minutes. As supernatant 
removed, cell pellet was resuspended at around one million cells per ml in MEF 
culture media. Cell number was counted again and cell suspension was further diluted 
5 
to required concentration, i.e. 1.4 X 10 cells per ml. 2 ml of cell suspension were 
placed on gelatin-coated 6-well dishes after excess gelatin was removed and incubated 
0 
in incubator at 37 C with 5% CO^ supply to allow cells to attach overnight. 
2.2 mESC culture and their differentiation 
2.2.1 mESC culture 
MESCs were cultured on a 6-well plate. Spent media was aspirated and washed by 
1ml PBS to remove any serum left behind. Then, 1 ml of 0.05% trypsin/ EDTA was 
0 
added and the 6-well plate was incubated in 37 C incubator for 5 minutes. After the 
plate was transferred to the cell culture hood, 1ml medium was then added to each 
well to stop trypsin reaction. Cell suspension was aspirated into 50 ml falcon and 
0 
centrifuge at 4 C, lOOOrpm for 5 minutes. Supernatant was aspirated, cell pellet was 
resuspended in mESC undifferentiated medium and one-tenth of cells were made up 
in 2.5 ml per one well of 6-well plate and seeded on fresh CD-I irradiated MEF for 
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0 
passage. The plate was returned to the 37 C incubator with 5% CO^ supply and 
moved in several quick, short, back-and-forth and side-to-side motions to further 
disperse cells across the surface of the wells. Cell culture media was refreshed daily 
for two to three days before next passage. 
2.2.2 Differentiation of mESCs 
MESCs were trypsinized and resuspended in undifferentiated medium as described in 
2.2.1. Part of the mESCs were seeded on MEF for passage, while the remaining cells 
0 
were seed on 0.1% gelatin coated 100 mm Petri dish and incubated at 37 C incubator 
for 30 minutes. This can remove MEF in cells mixture and so as to increase the purity 
of mESC for differentiation. After 30 minutes, cells were pipetted into 50 ml falcon 
0 
and centrifuged at 4 C，lOOOrpm for 5 minutes. Supernatant was removed and cell 
pellet was resuspended in 2ml medium to perform cell counting. Differentiation 
medium was added to the required amount of cells to make up to suitable volume, i.e. 
800 cells per 20 ji 1 hanging drop. By multi-channel pipette, 50 hanging drops were 
placed on the lid of 100 mm Petri dish carrying 20 ml PBS to prevent drying of 
0 
hanging drops. Petri dish with hanging drops was incubated in 37 C incubator with 
5% CO^ supply for 2 days. 
At differentiation day 2，embryoid bodies (EBs) developed in hanging drops were 
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monitored under inverted microscope to ensure single ball shape EB with normal size 
was formed in every hanging drop. Then, EBs were washed into 100 mm bacterial 
o 
grade petri dish in 10ml suspension and incubated in 37 C incubator with 5% CO^ 
supply for 5 days. 
At differentiation day 7, each EB was seeded onto one well of 0.1% gelatin coated 
24-well plate with 1 ml differentiation medium. The EBs were allowed to attach in 
0 
37 C incubator with 5% CO^ supply overnight. The next day was differentiation day 
7+1 and percentage of beating cells was begun to count and cells were collected on 
required days. 
2.3 Subcloning 
2.3.1 Amplification of Irx4 
Pairs of primers were designed flanking the full length of mouse Iroquois homeobox 
gene 4 {Irx4) sequence from vector pBSK-mIRX4 (kindly provided by Prof. 
Zheng-Zheng Bao in the University of Massachusetts Medical School) with the 
addition of Nhel and BsrGl restriction site to the 5' and 3' primer respectively and a 
clamp sequence (5' ACTGAC 3，）to both forward and reverse primers to facilitate 
restriction digestion (Table 2.1). Polymerase chain reaction (PGR) was performed in a 
25 III mixture with 0.3|xM each of the designed primers, IX Pfx amplification buffer, 
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IX enhancer buffer, 0.3 mM dNTP mixture, 1 mM MgSO^, 100 ng template DNA and 
1 unit of Platinum Pfx DNA polymerase (Invitrogen). PGR reaction was performed 
using PTC-200 DNA Engine (Petlier Thermal Controller) by denaturing at 94 for 2 
0 0 
minutes, followed by 35 cycles of amplification at 94 C for 15 seconds, 70 C for 30 
0 0 
seconds, 68 C for 2 minutes and 30 seconds, with a final extension at 68 C for 30 
seconds. 
The PGR product was analyzed on a 1% TAE agarose (Invitrogen) gel with 0.7 |ig/ml 
ethidium bromide (Invitrogen). The gel was visualized and photographed under ultra 
violet light, using UVitec DNA gel machine. 
Primers (5 丨-�3 丨） 
BsrGl ACTGACTGTACACCATTTAAAGCAGTTCAG 
Nhel ACTGACGCTAGCCGCTCTAGAACTAGTGGATC 
Table 2.1: Primers for addition of Nhel and BsrGl restriction sites on Irx4 insert 
2.3.2 Purification of DNA products 
PGR products were separated by DNA electrophoresis according to their sizes. 
T M 
Desired PGR products were visualized on a 2UV Transilluminator and then excised 
out and weighted. The DNA in gel pieces were purified using QIAquick DNA 
Extraction Kit (Qiagen) according to manufacturer's instructions as follows. The 
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excised gels were dissolved in 3 gel weight/ volumes (g/mL) of QC buffer at 55�C for 
15 minutes, with occasional shaking. One gel weight/ volume of isopropanol was 
added to the dissolved mixture to maximize the yield of DNA. The mixture was 
allowed to flow through QIAquick spin column that connected to a 2 ml collection 
tube. The column was then subjected to centrifugation at 13,000 rpm for 1 minute. 
The flow through was discarded and the column was washed once with 700 \il PE 
buffer. Again, the column was centrifuged at 13,000 rpm for a minute and the flow 
through was disposed. The membrane was air-dried for 3 minutes to remove any 
residual ethanol in the buffer. The membrane bound DNA was finally dissolved in 50 
\i\ of nanopure water for 2 minutes at room temperature and eluted by centrifugation 
at 13,000 rpm for 2 minutes. 
2.3.3 Restriction enzyme digestion 
Restriction enzyme digestion of the purified PGR product of Irx4 and the target vector 
iDuetlOlA (kindly provided by Prof. Linzhao Cheng at Johns Hopkins University) 
were performed in a 20 reaction mixture containing 10 units of insert/ vector, 1 unit 
of respective enzymes {Nhel and for Irx4, BsrGl and Xbal for iDuetlOlA) 
(New England Biolabs), 0.3 unit of BSA，IX NEB2 buffer and sterile nanopure water. 
0 
The reaction mixtures were incubated at 37 C for 3 hours for restriction digestion 
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0 
followed by heat inactivation at 65 C for 20 minutes. The digestion products were 
analyzed on a 1% TAE agarose gel and the target bands were excised and purified as 
described in section 2.3.2. 
2.3.4 Ligation of Irx4 with iDuetlOlA vector 
Ligation of the purified Irx4 and iDuetl01A plasmid was performed in a 20 |il 
reaction mixture containing IX ligation buffer, 10 ng digested and purified iDuetl01 A, 
30 ng of digested and purified Irx4 fragment, 400 units of T4 DNA ligase (New 
England Biolabs) and nano water. A negative control reaction was included in parallel 
0 
by replacing DNA insert with water. The reaction mixture was incubated at 16 C 
overnight for ligation. 
2.3.5 Transformation of ligation product into competent cells 
The frozen competent cells E. coli strain DH5a cells were thawed on ice for 10 
minutes. 10|il ligation mixture was mixed with 100 |il competent cells and incubated 
0 
on ice for 20 minutes. The cells and DNA mixture was then heat shocked at 42 C for 
90 seconds followed by a chill on ice for 3 minutes. After that，800 \i\ LB medium 
0 
was added for recovery and cells were incubated at 37 C for 1 hour under shaking at 
250 rpm. After incubation, bacterial cells were subjected to centrifugation at 6,000 一 
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SOOOrpm for 1 minute. The cell pellet was resuspended in 150 |il LB medium and all 
of the cell suspension was spread onto LB agar plate containing ampicillin (50|ig/ml). 
0 • . 
The plate was incubated at 37 C for overnight in an inverted position. 
2.3.6 Small scale preparation of bacterial plasmid DNA 
Colonies were picked on the next day of transformation and inoculated in 5 ml LB 
0 
medium containing 50p,g/ml ampicillin and incubated at 37 C, 250 rpm for 16 hours. 
The cloudy LB was centrifuged at 6,000 rpm for 5 minutes on the next day. The small 
scale preparation of bacterial plasmid DNA was done by QIAprep Miniprep Kit 
(Qiagen) according to manufacturer's instructions as follows. The cell pellet was 
resuspended in 250|il PI Buffer. Then, 250|il P2 Buffer was added to cell suspension 
and stood for 3 minutes to lyse the cells. 350 \i\ N3 Buffer was subsequently added to 
neutrallize the lysis buffer and cells were subjected to centrifugation at 13,000 rpm for 
10 minutes. The supernatant was then applied to the QIAprep spin column and 
centrifuged for another minute. The flow through was discarded and the QIAprep spin 
column was washed by the addition of 0.5 ml PB Buffer followed by centrifugation at 
13,000 rpm for 1 minute. Again, the flow through was discarded and the QIAprep 
spin column was washed once by addition of 0.75 ml PE Buffer followed by 
centrifugation at 13,000 rpm for 1 minute. An additional centrifugation at 13,000 rpm 
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for 1 minute was performed to remove any residual washing buffer. Finally, QIAprep 
spin column was placed in a clean 1.5 ml tube and 50 |il EB Buffer was added to the 
centre of the column. The column was let stood for 1 minute to allow DNA bound to 
the column to dissolve in the EB Buffer and DNA was then eluted by centrifugation at 
13,000 rpm for 1 minute. 
2.3.7 Confirmation of positive clones by restriction enzyme digestion 
The successful of ligation was preliminarily determined by restriction enzyme 
digestions. DNA prepared in 2.3.6 was digested with Pmel and 
I. The reaction conditions followed those on 2.3.3. 
2.3.8 DNA sequencing of the cloned plasmid DNA 
The exact sequence of the ligation product was confirmed by DNA sequencing 
performed by the commercial sequencing service TechDragon Company with four 
pairs of forward primers and one pair of reverse primers. Each primer can be used to 
read about 500bp of the sequence. Whole Irx4 gene plus the regions that flanked Irx4 
were sequenced. 
2.3.9 Large scale preparation of target recombinant expression vector 
After verification of the positive clones, 200iil of bacteria with target inserts were 
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inoculated into 150 ml LB medium containing ampicillin (50}j,g/ml). The culture was 
0 
incubated at 37 C, 250 rpm for 16 hours. Next day, the bacterial cells were harvested 
0 
by centrifugation at 6,000 x g at 4 C for 15 minutes. The large scale preparation of 
confirmed bacterial plasmid DNA was done by QIAprep Midiprep Kit (Qiagen) 
according to manufacturer's instructions as follows. After the supernatant was 
removed, the bacterial pellet was resuspended in 6 ml PI Buffer. Afterward, 6 ml of 
P2 Buffer was added, mixed vigorously by inverting the sealed tubes 4-6 times，and 
incubated for 5 minutes to lyse the cells. The resultant viscous cell lysate was then 
neutralized by 6 ml chilled P3 Buffer. The lysate was then poured into the barrel of 
the QIAfilter Cartridge and incubated at room temperature for 10 minutes. The cap 
from the QIAfilter outlet nozzle was then removed and a plunger was gently inserted 
into the QIAfilter Cartridge to filter the cell lysate into a previously QBT 
Buffer-equilibrated HiSpeed Tip. The clear lysate was allowed to enter the resin by 
gravity flow. When all lysate was flown through, the HiSpeed Tip was washed with 
20 ml QC Buffer and DNA was eluted with 5 ml QF Buffer. The DNA eluted was 
then precipitated by mixing with 3.5ml isopropanol and incubated at room 
temperature for 5 minutes. The precipitated DNA was subsequently passed through a 
QIAprecipitator under constant pressure and washed with 2 ml 70% ethanol. Finally, 
the DNA was eluted by 1ml Buffer TE. 
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2.4 Lentiviral vector-mediated gene transfer to mESCs 
2.4.1 Lentivirus packaging 
6 
6.4X10 HEK293FT at early passage were plated on T75 flask a day before 
transfection in 10ml medium with additional supplement of 2mM sodium pyruvate. 
DNA construct (either plasmid carrying Irx4 or iDuetlOlA) and the packaging 
plasmids (psPAX2 and pMD2.G) were co-transfected into the HEK293FT cells as 
described below. 
Two reaction mixtures were prepared in 50ml falcon; both contained 1.5ml 
OPTI-MEM (Invitrogen). 10 |ig psPAX2, 2.5 昭 pMD2.G and 5 昭 DNA construct 
were incubated with OPTI-MEM in the first falcon; while 50 i^l lipofectamine 2000 
was incubated with OPTI-MEM in the second falcon. The two reaction mixtures were 
allowed to incubate at room temperature for 5 minutes. They were mixed gently 
together and stood at room temperature for another 20 minutes. At the same time, 
spent medium of HEK293FT was replaced with 9ml of OPTI-MEM medium. After 20 
minutes, the 3ml reaction mixture was added to the HEK293FT cells and incubated at 
0 
37 C for 6 hours. OPTI-MEM I medium with the complexes was changed back to 
normal medium after 6 hours and lentiviruses were collected at 24, 48 and 72 hrs 
post-transfection. 
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2.4.2 Lentivirus titering 
5 
On day 1 , 3 x 1 0 HEK293FT cells were plated on each well of 24-well plate in 1ml 
medium. 6 wells were prepared for serial dilutions of lentivirus for each kind of 
viruses. On the next day, the cells were transduced with five, 5-fold serial dilutions in 
200 |il total volume while leaving one well as control. Since viruses tend to float on 
medium, 6 fxg/ml polybrene was added to draw them down to infect cells. 1 ml 
medium was added to each well on day 3. On day 4, spent medium was aspirated, and 
cells were washed by 0.5 ml PBS. 0.4 ml 0.05% trypsin/ EDTA was added to each 
0 
well and the 24-well plate was put into 37 C incubator for 5 minutes. 0.5ml medium 
was added to stop trypsin reaction. Cell suspension was then transferred to separate 
0 
centrifuge tubes and was centrifuged at 1,000 rpm，4 C for 5 minutes. After the 
supernatants were discarded, cells were resuspended in 0.5 ml PBS in each tube and 
cell numbers were counted. Afterward, cells were subjected to flow cytometry to 
determine the percentage of green cells per milliliter of cells, that is, the transduction 
unit per milliliter. 
2.4.3 Multiple transduction to mESCs 
MESCs at passage 16 were used for virus transduction. MESCs were trypsinized and 
resuspended in normal mESC medium. 0.5mL of 9.1 x 10^ mESCs was added with 
0.5mL virus and placed on a fresh monolayer of MEFs. After 12 hours, another 0.5mL 
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mESCs medium and 0.5mL virus with 6|ig/mL polybrene were added to these mESCs 
as the second round of transduction. After another 12 hours, all medium and viruses 
were aspirated and 0.5mL mESC medium and 0.5mL virus with 6p.g/mL polybrene 
were added as the third round of transduction. Finally, after an extra 12 hours, ImL of 
mESC medium was added to the mESCs for providing enough medium for 
maintenance. After another 12 hours, all medium and viruses were removed and these 
3-times-transduced mESCs were kept and splitted in a way the same as routine 
practice thereafter. 14 days after the last-round of transduction, the mESCs were 
plated on hygromycin-resistant MEFs (Chemicon) for antibiotic selection of 
positively transduced cells. 
2.4.4 Hygromycin selection on mESCs 
Hygromycin at 100 p-g/mL was used as the selection dosage. This was the 
concentration which resulted in 50% cell viability at day two as determined by the 
MTT assay. 
2.5 Selection of stable clone 
2.5.1 Monoclonal establishment and clone selection 
Selected mESCs were digested by trypsin to single cells. 100 cells were plated on one 
well of 6 well plate. When the colonies formed, they were picked under microscope in 
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static hood. The colonies picked was placed inside 1.5ml eppendorfs containing 
medium and digested mechanically by pipetting up and down. The cells were 
transferred to 24-well plate containing 1 ml medium. 
2.6 Differentiation of cell lines after selection 
After clone selection, differentiations of the mESCs line transduced with 
LV-iDuetlOlA- Irx4, positive control mESC line transduced with LV-iDuetlOlA and 
control mESC without transduction were performed. At and beyond day 7 of 
differentiation, EBs were remained in suspension instead of being attached. Medium 
was changed every 5 days. Cells were collected on differentiation day 0, day 3，day 7, 
day 7+10 and day 7+17. 
2.7 Gene expression study on control and to^-overexpressed mESC lines 
Total RNA was extracted from synchronized cells using Trizol reagent (Invitrogen) 
according to manufacturer's protocol. The resulting RNA was treated with DNase I 
(Invitrogen). First-strand cDNA was synthesized from 2|ig of the RNA using 
superscript III reverse transcriptase (Invitrogen). For real-time qPCR, gene-specific 
primers (purchased from Invitrogen) for the target and housekeeping genes were used. 
Power SYBR GREEN PGR Master Mix (Applied Biosystems) was used for qPCR 
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and the qPCR reactions were performed with 7500 Fast Real-time PGR system 
(Applied Biosystems). Each reaction was performed at least in triplicate under the 
following conditions: 50 °C for 2 minutes; 95 °C for 10 minutes; 40 cycles of 95 °C 
for 15 seconds, 57 °C 1 minute. Melting curve analysis and electrophoresis of PGR 
products were performed to verify the authenticity of PGR products. The threshold 
cycle (Ct) stands for the number of cycles for which SYBR Green signal generated 
was high enough to be recognized by the machine which also falls in the log phase of 
PCR amplification. The target gene was normalized to the housekeeping gene and the 
relative expression levels of different genes in experimental group were normalized to 
that in control group (i.e. the value in control cells were expressed at 1). Briefly，the 
amount of target and housekeeping gene in each sample was determined using their Ct 
values. The ACt value was determined by subtracting the housekeeping gene Ct value 
for each sample from the target gene Ct value of the sample. Calculation of AACt used 
control group as a reference. AACt was determined by subtracting the ACt of the 
experimental group from that of the control group. Fold-changes in the relative 
mRNA expression of the target gene were determined using the formula 
To study the effect of overexpression of Irx4 on cardiac differentiation of mESCs, a 
number of genes of the three cell lines mentioned above were being studied by qPCR. 
They included cardiac structure genes cardiac actin, alpha-myosin heavy chain 
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(a-MHC), cardiac troponin T (cTnT) and cardiac troponin I (cTnl); atrial-specific 
genes ANF, HRTl, and MLC-2a; ventricular-specific genes Irx4, Hrt2, KCNEl and 
MLC-2v. PGR primer sequences of these genes are listed in Table 2.2. Expression of 
Irx4 was studied on differentiation day 0, day 3, day 7, day 7+10 and day 7+17 while 
that of the other genes were studied on differentiation dayO, day? and day 7+17. 
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Primer Sequences Size GenBank Reference 
(bp) accession number 
a-Myosin Heavy (Rajan et al., 
Chain (a-MHC) 2006) 
5' Primer AGCTGACAGGGGCCATCAT 180 NM—010856.3 
3, Primer ACATACTCGTTCCCCACCTTC 
Cardiac Actin NM_009608.2 NCBI 
designing tool 
5 ‘ Primer CCAGCCCAGCTGAATCC 106 
3 ‘ Primer CC ATTGTC AC AC ACC AAAGC 
Cardiac Troponin I NM—009406.3 (Fijnvandraat 
(cTiiI) et a l , 2003) 
5 ‘ Primer AGGGCCCACCTCAAGCA 103 
3 ‘ Primer GGCCTTCCATGCCACTCA 
Cardiac Troponin T NM—011619.1 NCBI 
(cTnT) designing tool 
5' Primer TTCATGCCCAACTTGGTGCC 260 
3, Primer CTCTCTTCAGACAGGCGGTTC 
Myosin Light NM_022879.2 (Liu & Brent, 
Chain, Atrial 2005) 
(MLC-2A) 
5，Primer GGGTAAGTGTTCCGGAGGAA 98 
3 ‘ Primer GAGCTTCTCCCCGAAGAGT 
Myosin Light NM—0108(31.2 (Yuasa et al., 
Chain, Ventricular 2005) 
(MLC-2V) 
5' Primer GGGAGATGCTGACACACAAG 157 
3 ‘ Primer TTCAGGGCTCAGTCCTTCTCTT 
Atrial Natriuretic NM一008725.2 (Tsujita et al., 
Factor (ANF) 2006) 
5, Primer TCGTCTTGGCCTTTTGGCT 106 
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3 ’ Primer TCCAGGTGGTCTAGCAGGTTCT 
Irx4 NM_018885.1 NCBI 
designing tool 
5 ’ Primer GTGCC A AG AGCGA AGGTC AT 101 
3 ‘ Primer TCACATTCTGAGGTCTCTGCAT 
CT 
Hairy-related NM—010423.2 (Tang et al., 
transcription factor 2008) 
1 (HRTl) 
5，Primer CCAGGAAAAGACGGAGAGG 183 
3 ‘ Primer GCGCGTCAAAATAACCTTTC 
Hairy-related NM—013904.1 (Tang et al., 
transcription factor 2008) 
2 (HRT2) 
5, Primer CGTCGGGATCGAATAAATAA 191 
3 ‘ Primer GCACTCTCGGAATCCAATGC 
Potassium NM_008424.3 (Lambrecht et 




5' Primer ATCCTCATGGTGCTGGGCTTCT 208 
TC 
3 ‘ Primer CTACGGCCGCCTGGTTTTCAAT 
Beta-actin (Jabs et a l , 
5' Primer AGAGGGAAATCGTGCGTGAC 138 NM_007393.2 2004) 
3，Primer CAATAGTGATGACCTGGCCGT 
Table 2.2: Primers used in qPCR for expression of cardiac-specific genes 
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2.8 Analysis of mESCs at different phases of the cell cycle 
2.8.1 Go/Gi and S phase synchronization 
For synchronization of cell at GQ/GI phase, mESCs were first treated with 2.5mM 
thymidine (Sigma) for 12hr, then washed twice with prewarmed PBS and then 
released into prewarmed medium for 6 h. These cells were treated with 0.5 mM 
mimosine (Sigma) for 6hr. 
For synchronization at S phase, mESCs were first treated with 2.5 mM thymidine for 
12hr and then washed twice with prewarmed PBS and released into prewarmed 
medium for 12hr. MESCs were blocked by 2.5 mM thymidine again for another 12 hr, 
washed twice with prewarmed PBS and released into prewarmed medium for 3 hr. 
2.8.2 Cell cycle analysis by propidium iodide (PI) staining followed by flow 
cytometric analysis 
Cells were collected by trypsinization for subsequent cell cycle analysis. For analysis 
of DNA content, cells were fixed in 1 ml of 70% ethanol for 30 minutes at 4°C， 
rehydrated in 1 ml PBS. After that, PI staining was performed by treating the cells for 
30 minutes with RNase A (1 mg/ml) and 1 mg/ml PI. Fluorescence intensity was 
determined by flow cytometry on FACSCanto (BD Pharmingen). Data acquisition was 
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performed with the CellQuest software (BD Pharmingen), and the percentages of Gi, 
S and G2 phase cells were calculated with the MODFIT software program. 
2.8.3 Gene expression study by qPCR of Kv channel isoforms 
Expression at the mRNA level of Kv channels, Kyi.2, Kvl.3, Kyi.6 and BK, were 
assessed by qPCR in GQ/GI- and S phase-synchronized mESCs as described in section 
2.7. PCR primer sequences of these genes are listed in Table 2.3. 
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Primer Sequences Size (bp) GenBank Reference 
accession 
number 
Mouse Kv 1.2 (Liu et al., 
5’ Primer TCACCGACCCTTTCTTCAT 166 NM一008417.3 2005) 
3 ‘ Primer TCTGTCCCCAGGGTGATAA 
Mouse Kvl.3 NCBI 
5，Primer AGTATATGGTGATCGAAGAGGGG 137 NM_008418.1 designing 
3' Primer AGTGAATATCTTCTTGATGTTGACA tool 
Mouse Kvl.6 (Pirisino et 
5，Primer GGCTTCCTTCTCATGCTCAC 201 NM_013568.5 a l , 2004) 
3 ’ Primer GTGACTGATGGGCATGATTG 
Mouse BK (Wang et 
5' Primer CCATTAAGTCGGGCTGATTTAAG 188 NM_010610.2 a l , 2005; 
3’ Primer CCTTGGGAATTAGCCTGCAAGA Xue et al., 
2005) 
Beta-actin (Jabs et al., 
5, Primer AGAGGGAAATCGTGCGTGAC 138 NM一007393.2 2004) 
3 ’ Primer CAATAGTGATGACCTGGCCGT 
Table 2.3: Primers used in qPCR for the expression of Ky channel isoforms 
2.8.4 Membrane potential measurement by membrane potential-sensitive dye 
followed by flow cytometry 
To determine the membrane potential of the whole population of GQ/GI-phase 
synchronized mESCs and S-phase synchronized mESCs, staining by voltage-sensitive 
dye followed by flow cytometry was preferred to other methods. GQ/GI. and S-phase 
synchronized mESCs were prepared as described above. After trypsinization, they 
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were divided into two groups: unstained group and DiBAC4(3)-treated group in which 
cells were resuspended in 500ul HEPES solution (135mM NaCl, 5mM KCl，2mM 
CaCl2.2H20, 1.2mM MgCh, lOmM HEPES and 5mM glucose) and incubated with 
500nM DiBAC4(3) (Invitrogen) for 10 minutes at 37°C (Marie et al., 1998; 
Petkova-Kirova et al., 2000). Cells were used directly for membrane potential 
measurement after incubation. Fluorescence intensity was determined by flow 
cytometry on FACSCanto (BD Pharmingen). Winmdi software program was used to 
generate picture of unstained and DiBAC4(3)-treated group overlay. Peaks of 
unstained populations of two groups were aligned so that the difference between 
stained populations could be determined. 
2.9 Apoptotic study 
Control feeder free mESCs and TEA+-treated feeder free mESCs were started at a 
concentration of SxlO'^/well on 6-well plates. Medium of both groups were changed 
everyday for five days starting from the next day. lOmM TEA+ containing medium 
was used in the TEA+-treated group while plain medium was used for control group. 
Cells from both groups were split at 1:20 ratio two days later and were ready for 
subsequent experiments after five days. 
Control feeder free mESCs and 5-day-TEA+-treated feeder free mESCs were 
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trypsinized and washed with PBS (invitrogen). 1x10^ cells of each cell type were 
resuspended in 0.5ml Annexin V binding buffer (lOmM HEPES at pH 7.4, 140mM 
NaCl, 2.5mM CaCb). 0.5ml 2X staining solution (5^1 Annexin V-GFP solution, l^il 
2mg/ml propidium iodide solution (Sigma) and 0.5ml Annexin V binding buffer) was 
added to the samples and incubated at room temperature for 15min. After staining, the 
samples were subjected to flow cytometry (FACSCanto, BD Pharmingen) to 
determine the percentage of necrosis and apoptosis of each sample. 
2.10 Determination of pluripotent characteristic of mESCs 
2.10.1 Expression of germ layers' markers by qPCR 
Expression at the mRNA level of germ layers' markers, Cdx2, eHand, HNF-1(3, Mixll， 
nodal, soxl and braychyury T were assessed by qPCR as described in section 2.7. 
PCR primer sequences of these genes are listed in Table 2.4. 
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Primer Sequences Size (bp) GenBank Reference 
accession no. 
Cdx2 (Liu et al., 
5' Primer GCGAAACCTGTGCGAGTG 140 NM_007673.2 2005; Scholl 
et al., 2007) 
3, Primer GACTAAAGTGAAACTCCTTCTCCAGC 
eHand 
5' Primer CAAACGAAAAGGCTCAGGAC 150 NM一008213.2 By primer 
3, Primer ATGTAACTGGTAGCCAGGCG express 3.0 
HNF-lp (Pirisino et 
5' Primer CCCAGCAATCTCAGAACCTC 99 NM—009330.2 al., 2004) 
3 ‘ Primer AGGCTGCTAGCCACACTGTT 
Mixll (Wang et al., 
5' Primer AACCGACGGGCCAAGTC 66 NM_13729.2 2005; Xue et 
al., 2005) 
3 ‘ Primer TCCCCGCCTTGAGGATAAG 
Nodal 
5' Primer ACTTTGCTTTGGGAAGCTGA 140 NM_013611.3 NCBI 
3 ‘ Primer ACCTGGAACTTGACCCTCCT designing tool 
Soxl 
5' Primer GAGTGGAAGGTCATGTCCGA 133 NM_009233.2 (Yao et al., 
3' Primer TCTTGAGCAGCGTCTTGGTC 2007) 
Brachyury T (Ueno et a l , 
5' Primer GAACCTCGGATTCACATCGTGAGA 159 NM_009309.2 2007) 
3, Primer ATC AAGG A AGGCTTTAGC A A ATGGG 
Beta-actin (Jabs et al., 
5' Primer AGAGGGAAATCGTGCGTGAC 138 NM_007393.2 2004) 
3 ’ Primer CAATAGTGATGACCTGGCCGT 
Table 2.4: Primers used in qPCR for the expression of germ layers markers 
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2.10.2 Differentiation by hanging drop method and suspension method 
For EB assays, 0.3% methylcellulose-containing medium without LIF was used in the 
assays. Control feeder free mESCs and 5-day-TEA+-treated feeder free mESCs were 
trypsinized and resuspended in medium. For suspension method, 1 x 1 c e l l s were 
plated in 10ml medium in 10-cm bacterial-grade dishes. 
For hanging drop method, medium was added to the required amount of cells to make 
up to suitable volume, i.e. 800 cells per 20 |il hanging drop. 50 hanging drops were 
placed on the lid of 10-cm bacterial-grade dishes carrying 20 ml PBS to prevent 
drying of hanging drops for 2 days. At differentiation day 2, EBs developed in 
handing drops were checked under inverted microscope to compare the sizes and 
shapes of EBs from both group. After that, EBs were washed into 10-cm 
bacterial-grade dishes in 10ml medium for another 5 days. 
EBs were analyzed at day 7 of differentiation. The numbers of EBs were counted 
under the microscope while the sizes of EBs were measured using the SPOT Imaging 
Software Advanced (Diagnostic Instruments Inc.). EBs were also collected and stored 




3.1 mESC culture 
• • 
Fig. 3.1: A) Appearance of undifferentiated mESC colonies growing on the MEFs. 
Healthy mESCs are with distinct border and homogeneity. B) Appearance of 
feeder-free mESCs. 
3.1.1 Cell colony morphology of feeder free mESCs 
After removing MEFs from the culture, it was observed that feeder-free mESC 
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colonies had an irregular contour (Fig. 3.IB). After 30 passages of mESCs in the 
feeder-free system, mESCs were allowed to grow on MEFs again. The mESC 
colonies, after being re-plated and allowed to grow on MEFs, became round-shaped, 
in a way similar to what was observed in the colonies routinely cultured on feeder 
layer (Fig.3.1 A). 
3.2 Subcloning 
3.2.1 PGR cloning oiIrx4 
To prepare Irx4 carrying plasmid with hygromycin selection marker and under control 
of EF-la promoter, Irx4 and iDuetlOlA were used as insert and vector backbone 
respectively. Irx4 insert was amplified by PGR from pBluescript SK- (Fig. 3.2) with 
the addition of Nhel and ^^rGI restriction sites by the designed primers as shown in 
Table 2.1. PGR products were analyzed on an agarose gel and single band of Irx4 was 
shown in Fig. 3.3. After restriction digestion of the amplified DNA fragment with 
Nhel and Irx4 insert with sticky ends were generated (Fig. 3.6). 
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Fig. 3.2: Vector map showing Irx4 in pBluescript SK- plasmid 
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Fig.3.3： Gel photo showing the bands after amplification of Irx4 in pBluescript SK-
plasmid with Nhel and BsrGl cutting ends by PGR. The fragment with 1831 bp was 
extracted and purified for subsequent ligation with iDuetlOlA. 
3.2.2 Restriction digestion on iDuetlOlA 
On the other hand, backbone iDuetlOlA was cut opened by restriction enzymes Xbal 
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and jBsrGI (Figs.3.4 and 3.5). This produced two fragments with size 740bp and 
10686bp. The former carried GFP gene while the latter was extracted for ligation 
(Fig.3.6). 
Xbal BsrGl 
Fig.3.4: Schematic diagram showing the location of restriction sites of Xbal and 
BsrGl of lentiviral vector iDuetlOlA. 
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Fig. 3.5: Vector map showing restriction sites of iDuetlOlA 
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Fig.3.6: Gel photo showing the specific band after amplification of Irx4 by PGR; the 
backbone and GFP formed by restriction digestion of iDuetlOlA using Xbal and 
BsrGl; and the uncut control of iDuetlOlA (left to right). 
3.2.3 Ligation of Irx4 to iDuetlOlA backbone 
Ligation was performed at 16�C overnight and the vector map of the resultant vector 
was shown in Fig. 3.7. 
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Earn 1105 ^^^^^^^ 
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Av?" i 丁etcr V 
P"工乂 乂 / 
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S^ l^ Ball 
PshAI r>ccB7l 
BsrGl BsaBI 
Fig. 3.7: Vector map of the resultant lentiviral vector with GFP in iDuetlOlA being 
replaced by the Irx4 gene. 
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3.2.4 Confirmation of successful ligation 
On the next day, the ligation products were transformed into DH5a strain of E.coli. 
Clones were re-grown in LB for small scale preparation of plasmids. Restriction 
digestions with Xbal and Pmel (Fig.3.8) and DNA sequencing (data not shown) were 
carried out to confirm the identity of the ligation product. 
Ligation uncut 
SOOObp •二 J P ^ W m 
j l ^ m 
Fig. 3.8: Gel photo showing the products of restriction digestion of resultant lentiviral 
vector using Xbal and Pmel enzymes as preliminary confirmation. Products of 
expected sizes were seen. The ligation product was also sent for sequencing to 
confirm the identity of the resultant clone (data not shown). 
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3.3 Lentivirus packaging 
3.3.1 Transfection 
LVs were prepared and titered as mentioned (see section 2.4). Transfection efficiency 
was checked under fluorescent microscope (Fig. 3.9). LVs were collected from the 
supernatant at three time intervals: 24, 48 and 72 h post-transfection. The LV titering 
performed by flow cytometry was shown in Fig. 3.10. The LVs packaged were ready 
6 
for use with titer of 2.00 X 10 TU/ml. 
Fluorescence Bright Field 
• • 
Fig. 3.9: HEK293FT viewed under fluorescence microscope. Green fluorescent signal 
was observed during virus production in cells transfected with iDuetlOlA which 
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Fig.3.10: Shift ofFITC signal of LV-iDuet 101A transduced HEK293FT. 
Transduction Units (TU) 
=(No. of cells) X (percentage ofFITC positive cells) x (dilution factor) x5 /100 
=4.47x10^ X 89.81% x 1 x 5/100 
=2.00 X 10^ TU/ml 
3.4 Multiple transduction of mESCs and hygromycin selection of 
positively-transduced cells 
MESCs were transduced for multiple times and positively transduced mESCs were 
selected by hygromycin as described in the 'materials and methods' section. After 
hygromycin selection at 100|ag/ml for 14 days, transduced mESCs appeared healthy. 
For mESCs transduced with LV-iDuetlOlA, colonies remained and still showed green 
fluorescence (Fig. 3.11), indicating mESCs were successfully transduced and selected. 
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Fig.3.11: LV-iDuetlOlAtransduced mESCs examined under fluorescent microscope 
after hygromycin selection. Fluorescence (left); bright field (right) 
3.5 FACS 
To study the efficiency of hygromycin selection, percentage of FITC positive was 
studied in LV-iDuetlOlA transduced mESC, while non-transudced mESCs acted as 
negative control. Since MEFs were presented in together with the cell lines under 
investigation, and would autofluorescent, they were also included. From the result, 
27.6% of MEF was FITC-positive. However, the pattern of peak as shown in FACS 
was different from that of iDuetlOlA. Therefore, we can conclude that the FITC 
signal from MEF did not interfere with that from iDuetlOlA. 74.1% of iDuetlOlA in 
the cell population were FITC positive and thus transduced with iDuetlOlA. Since 
Irx4 and iDuetlOlA shared the same vector backbone and under the same promoter 
EF-la, we can roughly estimate the percentage of Irx4 was transduced with Irx4 from 
the result of iDuetlOlA (Fig. 3.12). 
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Fig.3.12: The percentage of FITC positive signal in four different cell lines 
3.6 Irx4 and Iduet clone selection 
Clones were established as described in 2,5.1. There were a total of seventeen clones 
picked, among them, eight of them could grow up. Among these eight clones, clone 4 
and clone 7 were of significantly slower growth rate when compared with both control 
mESCs or Iduetl 01A clone 2 (Iduet2) (data not shown). Other six clones were of 
similar growth rate when compared with Iduet2. In addition, among all these eight 
clones, Irx4 clone 17 (Irx4 17) has the highest Irx4 expression as determined by 
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western blot (Fig. 3.13) and was chosen for subsequent uses. On the other hand, 
Iduet2 was also selected as a transduction control due to its stable growth rate and 
high FITC positive signal. Later, the average fold change of Irx4 expression was 
compared between Irx4 17, control mESC and Iduet 2，among which Iduet 2 acted as 
control. Irx4 17 showed the highest expression among the cell lines (4.06 士 1.83 for 
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Fig.3.13: A) Western blot of the eight /rx^-transduced clones established. Among 
them, clone Irx4 17 has the highest Irx4 expression and therefore was selected for 
subsequent experiments. B) Expression of Irx4 among Irx4 17, mESC and Iduet 2 by 
western blot. Irx4 17 has the highest Irx4 expression among the three cell lines. (n=3) 
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3.7 Characterization of mESCs after clone selection 
3.7.1 Immunostaining of pluripotent and differentiation markers 
Characterization was carried out to ensure the undifferentiated status of the mESCs 
after the selection. Immunofluorescence staining of pluripotent and differentiation 
markers showed that mESCs were well-kept in undifferentiated state (Fig. 3.14). 
A) mESC unstain SSEA-1 




B) Unstain SSEA-1 
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Fig. 3.14: A) MESC, B) Iduet 2 and C) Irx4 17 colonies were stained with anti-0ct4, 
anti-SSEAl and anti-SSEA4 antibodies and were examined under fluorescent 
microscope. All types of colonies were stained positively with Oct-4 and SSEA-1 but 
not SSEA-4, indicating that they were in undifferentiated states. 
3.8 Differentiation of cell lines after selection 
To study the effect of overexpression of Irx4 gene on cardiac gene expression, 
differentiations of the mESCs line Irx4 17, transduced control mESC line Iduet 2 and 
control mESC without transduction were performed. Samples were collected on 
differentiation day 0，day 3，day 7, day 7+10 and day 7+17 for subsequent qPCR 
analysis. 
3.8.1 Size of EBs of the cell lines during differentiation 
Sizes of EBs of the three cell lines were closely monitored during differentiation 
(n=3). At the early phase of differentiation (i.e. day 3 to day 7), EBs sizes of mESC 
were much larger than those of Iduet 2 and Irx4 17 (representative photos of EBs sizes 
were shown in Fig. 3.15). Starting from differentiation day 7+10, EBs of mESC and 
Iduet 2 shared similar morphology and sizes, while those of Irx4 17 still appeared 
smaller. However, something interesting occurred afterward. EBs sizes of Irx4 17 
increased abruptly. They showed similar EB size as those of Iduet 2 at differentiation 
day 7+17, while those of mESC appeared smaller. 
國 
Fig. 3.15 Representative graphs showing the sizes of EBs of A) mESC B) Iduet 2 C) 
Irx4 17 at differentiation day 7. The size of EBs of mESC was the biggest and most 
condense among three, followed by Iduet 2 and then Irx4 17. The calibration bar 
represents lOO i^M. 
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3.9 Gene expression study by qPCR 
After reverse transcription of mRNA into cDNA and confirmation of cDNA quality 
by PGR, qPCR was performed to check for the cardiac specific gene expression level. 
Expression at the mRNA level of cardiac structural genes, atrial-specific genes and 
ventricular-specific genes of the 3 cell lines was determined by qPCR at 
differentiation day 0, day? and day 7+17 {n = 2-3, data of mESC not shown). Among 
the time points being studied, gene expression at day 7+17 showed the major 
differences. In the three classes of genes being studied, cardiac structural genes 
showed the largest upregulation in Irx4 17, the cell line of our interest, when 
compared with control Iduet 2, except the expression of cTnl (39.53 士 1.34, 14.47 士 
12.92 and 17.00 士 5.90 of that in I duet 2 for cardiac actin, alpha MHC, cTnT, 
respectively; p<0.05 for cardiac actin when values in Irx4 17 were compared with 
1.00 士 0.00 in Iduet 2) (Fig. 3.16). On the other hand, the expression of cTnl was 
quite similar in Irx4 17 and Iduet 2 cells (1.91 士 0.89 Vs 1.00 士 0.00 for Irx4 17 and 
Iduet 2 cells; p>0.05 when values in Irx4 17 were compared with 1.00 士 0.00 in Iduet 
2) (Fig. 3.16). Interestingly, Irx4 17 showed increases in expressions of many of the 
atrial- and ventricular-specific genes when compared with Iduet 2 at the same 
differentiation time point. For atrial-specific genes, ANF and MLC-2a were 
upregulated in Irx4 17 at day 7+17，when compared with control Iduet 2, whilst the 
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expression of HRTl showed similar expression level in both cell lines of all time 
points being studied (9.69 士 5.41 and 12.97 士 4.44 of that in Iduet 2 for ANF and 
MLC-2a, respectively; 1.12 士 0.18 for HRTl) (Fig. 3.17). On the other hand, SLN 
was undetectable in both cell lines at all time points being studied (data not shown). 
For ventricular-specific genes, only MLC-2v showed major difference among the 3 
ventricular genes being studied at day 7+17, while expressions of HRT 2 and KCNEl 
were similar in both cell lines (7.62 士 2.39 of that in Iduet 2 for MLC-2v mRNA; 1.51 
士 0.36 and 1.50 士 0.66 for HRT2 and KCNEl, respectively) (Fig. 3.18). 
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Fig. 3.16: Average fold changes of various cardiac structural gene markers: A) cardiac 
actin, B) alpha MHC, C) cTnT and D) cTnl in Iduet 2 and Irx4 17. Cardiac structural 
gene A) to C) of Irx4 17 at day 7+17 generally showed a higher expression than those of 
Iduet 2 while similar expression was observed at earlier differentiation time points. On 
the other hand, expression of cTnl in two groups was quite similar, with Irx4 17 showed 
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Fig. 3.17: Average fold changes of various atrial-specific gene markers: A) ANF, B) 
MLC-2a and C) HRTl in Iduet 2 and Irx4 17. ANF and MLC-2a in Irx4 17 at day 7+17 
generally showed a higher expression than those of Iduet 2 while similar expression 
was observed at earlier differentiation time points and in HRTl of all time points. 
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Fig. 3.18: Average fold changes of various ventricular-specific gene markers: A) 
MLC-2v, B) HRT2 and C) KCNEl in Iduet 2 and Irx4 17. MLC-2v in Irx4 17 at day 
7+17 showed a higher expression than that in Iduet 2. Expression of HRT2 and KCNEl 
showed less obvious difference 
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3.10 Kv channel expression and membrane potential of mESCs at GQ/GI phase 
and S phases 
MESCs were treated with drugs to arrest them in different phases of the cell cycle (see 
section 2.8.1 for details). Fig. 3.19 showed the DNA content of cells after cell cycle 
synchronization as determined by flow cytometry. Thymidine plus mimosine 
treatment resulted in 56.35 士 5.78 % of the cells blocked in GQ/GI phase, a result 
similar to what have been obtained in other study (Fujii-Yamamoto et al , 2005). For 
simplicity, we referred these synchronized cells as 'GQ/GI phase-synchronized cells'. 
On the other hand, double thymidine block followed by 3-hour release synchronized 
all cells in S phase (100.00 士 0.00 %) (‘S phase-synchronized cells') (Fig. 3.20). 
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Fig. 3.19 Representative graphs showing cell cycle profiles of (a) asynchronously 
growing mESCs (n=7), (b) GQ/GI-synchronized mESCs (n=7) and (c) S phase 
synchronized mESCs (n=14). The percentage of the GQ/GI, S, and G2/M phase 
populations were estimated by ModFit software program. 
*** 
^ 100- ‘ I I Thymidine + mimosine (TM) 
已 I I Double Thymidine + 
o 80- 3 hr release (DTR) 
* * * 
^ I I 




^ *** p<0.001 ’ DTR group Vs TM group 
0) 2 0 -
O 丁 
o-U 
G 0 / G 1 S G 2 / M 
Fig 3.20 Cell cycle distribution of 'GQ/GI-phase synchronized' mESCs and ‘S-phase 
synchronized' mESCs. Values are expressed as mean 士 S.E.M.. *** p<0.001 when 
thymidine plus mimosine group ('GQ/GI-phase synchronized' mESCs) Vs that of 
double thymidine block plus 3-hour release group ('S-phase synchronized' mESCs). 
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3.10.1 Expression of Kv channels subunits at GQ/GI phase and S phase 
In the previous study, a number of Ky channel mRNAs were found to be present in 
undifferentiated mESC cultured on feeder layer (Wang et al., 2005). In the same study, 
potassium currents, which were activated by depolarization and were non-inactivating, 
were detected (Wang et al., 2005). Since these currents are typical of delayed rectifier 
and large-conductance calcium-activated potassium channels (BK), therefore, Kyl.l, 
Kvl.2, Kvl.3, Kvl.4, Kvl.6 and BK were further studied in the present investigation. 
In the present study, Kvl.l was failed to be detected at mRNA level while it was 
detected in positive control using the same pair of primers (data not shown). It may be 
due to the fact that feeder-free mESCs were used in the present study. On the other 
hand, expression at the mRNA level of Kvl.2, Kvl.3, Kvl.6 and BK were determined 
by qPCR in GQ/GI phase- and S phase-synchronized mESCs {n = 5). Kvl.2, Kvl.6 and 
BK channels genes were found to be downregulated in GQ/GI -synchronized cells (0.33 
士 0.09，0.45 士 0.17 and 0.25 士 0.09 of that in S phase for Kvl.2, Kvl.6 and BK mRNA, 
respectively; p<0.05 when values in GQ/GI phase were compared with 1.00 士 0.00 in S 
phase). On the other hand, the expression of Kvl.3 remained the same in GQ/GI phase-
and S phase-cells (1.13 士 0.44 Vs 1.00 士 0.00 for GQ/GI phase- & S phase-cells; 
p>0.05) (Fig. 3.21). 
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Fig. 3.21 QPCR results of different KY isoforms in 'GQ/GI-phase synchronized' 
mESCs and 'S-phase synchronized' mESCs. Lower expressions of Kyi.2, Kyi.6 and 
BK channels were detected in 'GQ/GI-phase synchronized' mESCs. Expressions of 
'Go/Gi-phase synchronized' mESCs were normalized to that of ' S-phase 
synchronized' mESCs. Values are mean 土 S.E.M. of five experiments. * p<0.05 & ** 
p<0.01 for values of 'GQ/GI-phase synchronized' mESCs Vs that of 'S-phase 
synchronized' mESCs. 
3.10.2 Membrane potential at GQ/GI phase and S phase 
Fig. 3.22 shows the representative trace of the FITC intensity between unstained 
group and DiBAC4(3)-treated group. DiBAC4(3) is a membrane potential sensitive 
dye which partitions into the cells according to membrane potential. It leads to 
increase in fluorescence intensity during membrane depolarization [(Marie et al., 
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1998)]. S-phase synchronized mESCs showed a relatively lower FITC intensity than 
that of GQ/GI-phase synchronized mESCs. This indicated that mESCs at GQ/GI phase 
were more depolarized than those at S phase. 
§1 G0/G1 phase-synchronized 
S phase-synchronized 
"LA 
10� 10' 10- 10* 10' 
FITC-A 
Fig. 3.22 Representative traces of membrane potential of "GQ/GI -phase 
synchronized" mESCs and 'S-phase synchronized' mESCs as determined by 
voltage-sensitive dye followed by flow cytometry. 'GQ/GI -phase synchronized' 
mESCs were more depolarized when compared with 'S-phase synchronized' mESCs. 
Similar data were obtained from three independent experiments. 
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3.11 Effects of TEA+ on feeder free mESCs 
3.11.1 Apoptotic study 
Previous studies from our group showed that Ky blockade in mESCs can lead to 
attenuation of increase in cell number (Ng et al., 2009; Wang et al., 2005). However, 
the role of Kv channels in the fate determination of mESCs has not been dissected. To 
investigate if the function of Kv channel can affect the survival of mESCs, the effect 
of Kv channel blockade on apoptosis of mESCs was determined by staining with 
Annexin V-GFP and propidium iodide. Annexin V is a dependent protein that 
binds tightly to phosphatidylserine (PS). During early phase of apoptosis, PS will be 
translocated from the inner face of the plasma membrane to the external cellular 
environment. Propidium iodide is a red fluorescent nucleic acid stain which only 
penetrates cells with damaged membrane. Therefore, using Annexin V-GFP and PI, 
the apoptotic cells, necrotic cells and normal cells can be identified through the flow 
cytometric analysis. 
It was found that blockade of Kv channels by TEA+ did not induce apoptotic cell 
death in mESCs (Fig. 3.23). This indicated that functional Kv channels determine the 
fate of mESCs by a mechanism other than controlling apoptosis. 
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Fig. 3.23 Effects of TEA+ treatment on apoptosis of mESCs. A) Treatment of mESCs 
with lOmM TEA+ for 5 days did not increase the percentage of cells undergoing 
necrosis or apoptosis. Positive control (necrosis control) was performed by adding 
30|j,g digitonin to induce necrosis. Values are mean 士 S.E.M. of four experiments. B) 
Representative flow cytometry results showing unstained control, solvent control, 
TEA+ treatment and necrosis control groups. Q2, Q3 and Q4 represent necrotic, live, 
and apoptotic cells，respectively. 
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3.11.2 Expression of germ layers' markers 
Since the attenuation of increase in mESC number by Kv channel blockade can be 
attributed to differentiation, the expression of germ layer markers were investigated. 
Expression at the mRNA level of early germ layer markers, Cdx2, eHand 
(trophectoderm), HNF-1(3 (endoderm)，Mixll, Brachyury T (mesoderm), Nodal 
(mesendoderm) and Soxl (ectoderm) were assessed by qPCR in control and 
TEA+-treated mESCs (n = 4). eHand, HNF-ip, Mixll and Nodal genes were found to 
be upregulated in TEA+-treated mESCs (2.32 士 0.22, 3.44 士 1.15, 1.52 士 0.02 and 
2.20 士 0.45 of that in control mESCs for eHand, HNF-lp, Mixll and Nodal). On the 
other hand, the expression of Soxl was downregulated in TEA+-treated mESCs when 
compared with that in mESCs (0.78 士 0.02 Vs 1.00 士 0.00) (Fig. 3.24). Cdx2 and 
Brachyury T were undetectable in TEA+- treated mESCs but they were detectable in 
control mESCs, suggesting that their expression were also downregulated when Kv 
channels were blocked. 
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Fig. 3.24 Expression of various germ layer markers in TEA+-treated and control 
mESCs. The expressions of eHand, HNF-lp, mixll and nodal were found to be 
upregulated while expression of soxl was downregulated. Brachyury T and Cdx2 
were not detectable in TEA+-treated group while they were detectable in control group, 
suggesting that TEA+ treatment also led to a downregulation of these two genes. 
Expressions of genes in TEA+-treated mESCs were normalized to that of control 
mESCs. Values are mean 士 S.E.M. of three to four experiments. * p<0.05, ** p<0.01 
& *** p<0.001 for values of TEA+-treated mESCs Vs that of control mESCs. 
3.11.3 Embryoid bodies (EBs) measurement after differentiation 
As shown above, blockade of Kv channels in mESCs led to differentiation and hence 
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a loss of pluripotency at molecular level. To further investigate the functional 
consequences of Kv channel blockade on mESC differentiation potential, control and 
TEA+-treated mESCs were subjected to differentiation. Two commonly used 
differentiation methods, the hanging drop method and the suspension method, were 
performed. Pre-differentiation TEA+ treatment on mESCs led to decrease in 
differentiation as shown by a significant reduction in the sizes of EBs formed. For 
differentiation by hanging drop method, diameters of control EBs were of average 
356.2 士 8.9^im while EBs differentiated from TEA+-treated mESCs had average 
diameter of 290.8 士 5.6|im (p<0.001 Vs control) at differentiation day 7 (Fig. 3.25). 
Similar results were obtained when mESCs were differentiated by suspension method; 
at differentiation day 7, control EBs had average diameter of 167.0 士 7.3|im while 
EBs differentiated from TEA+-treated mESCs had average diameter of 100.5 士 3.4|iin 
(p<0.001 Vs control). These results clearly demonstrated that Kv channel blockade in 
mESCs can lead to loss of pluripotency, which would in turn affect the differentiation 
potential of mESCs upon differentiation at functional level. 
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Fig. 3.25 Effects of TEA+ treatment on the differentiation potential of mESCs. A) 
MESCs were treated with lOmM TEA+ for 5 days before they were subjected to 
differentiation by hanging drop or suspension methods. TEA+ pre-treatment before 
differentiation led to the formation of much smaller EBs as judged from their 
diameters by these two different differentiation methods. Values are mean 士 S.E.M. of 
two to three independent experiments with over 80 EBs counted in each group. *** 
p<0.001 Vs control group. B) Representative photos showing the EBs formed by 




4.1 Effect of overexpression of Irx4 on the cardiogenic potential of mESCs 
One of the objectives of this project is to drive mESCs differentiation to ventricular 
cardiomyocytes by overexpression of a ventricular-specific gene: Irx4. Irx4 has a 
ventricular-restricted expression pattern at all stages of chick and mouse heart 
development. It was also shown to regulate the chamber-specific gene expression by 
activating the expression of the ventricle-specific genes and suppressing the 
expression of the atrial-specific genes (Bao et al., 1999; Bruneau et al., 2000). 
Previous studies have shown that overexpression of cardiac-specific transcription 
factor(s) can direct differentiation preferentially to cardiac lineage and increase the 
yield of cardiomyocytes accordingly (Grepin et al., 1997; Monzen et al., 1999). 
Therefore, we hypothesized that by overexpression of ake y ventricular 
cardiomyocyte-specific transcription factor Irx4, ESCs differentiation will be 
genetically driven to ventricular cardiomyocyte differentiation and the yield of 
ventricular cardiomyocytes will be increased. This is the first study in investigating 
the effect of overexpression of Irx4 in mESCs. 
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From the preliminarily qPCR results, overexpression of Irx4 resulted in an major 
increase in expression of cardiac genes cardiac actin, a-MHC, cTnT, ANF, MLC-2a 
and MLC-2V at day 7+17. On the other hand, the expressions of cTnl, HRTl, HRT2 
and KCNEl were similar to those of control iDuet 2. Interestingly, those with 
increased expression (except ANF) were cardiac structural genes, either from atria or 
ventricles. The results implied that overexpression of Irx4 favored general cardiac 
structural genes expression, in particular in the late differentiation stage. 
It is at present unknown why only structural genes but not transcription factors were 
affected by altering the expression of Irx4. Bioinformatic study is needed in the future 
to predict if the promoters of these structural genes are regulated preferentially by Irx4 
but not that of the transcription factors under the present investigation. 
In addition, it is interesting that Irx4 overexpression increased cardiac differentiation 
in general but not specifically into a particular cardiac cell types (e.g. ventricular 
cells), in contrast to what have been observed in chick in which overexpression of 
Irx4 in heart led to a downregulation of atrial-specific gene (Bao et al., 1999). Since in 
the present investigation, Irx4 was overexpressed constitutively in all the lineages but 
not specifically in cardiac cells, it is possible that Irx4 downregulated other gene(s) 
96 
which is/are important for differentiation into other lineage(s) that originally 
negatively interfere with cardiac differentiation. It was found previously that 
activation of the Wnt/p-catenin pathway during mESC differentiation would have 
opposite effect on cardiac and hematopoietic lineages: during early phase of 
differentiation, activation of Wnt/p-catenin would enhance ESC differentiation into 
cardiac lineage while suppressing differentiation into hematopoietic lineages (Naito et 
al., 2006). Consistently, Wnt2 -/- EBs have impaired terminal cardiac differentiation, 
but enhanced hematopoietic cell differentiation (Wang et al., 2007). Also, Wnt-1 
overexpression led to enhanced cardiomyogenesis and inhibition of hematopoiesis in 
mESCs (Weisel et al.，2009). In addition, pharmacological inhibition of BMP 
signaling during the early mESC differentiation was found to promote cardiac 
differentiation in the expense of other mesodermal lineages such as hematopoietic 
lineage (Hao et al., 2008). Using fate mapping method in zebrafish, it was found that 
Hand2-expressing mesoderm had cardiac progenitor while hematopoietic progenitor 
cells were found in area beyond the rostral boundary of Hand2 expression; 
interestingly, in embryos deficient in hematopoietic specification, rostral mesoderm 
underwent a fate transformation and generated ectopic cardiomyocytes (Schoenebeck 
et al., 2007). Taken together, hematopoietic differentiation and cardiac differentiation 
were found to be regulated in an opposite way and that hematopoietic specification 
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represses cardiac specification. Worth to note, it is well-studied that retinoic acid (RA) 
and 1,25 a-dihydroxycholecalciferol (vitamin D3) are potent regulators of 
hematopoietic differentiation (Botling et al., 1996; Brown et al., 1997; Defacque et al , 
1996; Nakajima et al., 1996). Both VDR and RXRa are involved in the monocytic 
differentiation upon Vitamin D3 treatment (Defacque et al., 1996). In addition, RXR 
forms a heterodimer with retinoic acid receptor (RAR) and VDR, enabling their 
efficient transcriptional activation, affecting the monocytic differentiation (Brown et 
al., 1997; Nakajima et al., 1996). Since, as mentioned in previous section, it was 
found that Irx4 forms an inhibitory complex with the vitamin D and RXRa to regulate 
cardiac chamber-specific slow MyHC3 expression (Wang et al., 2001). Therefore, it is 
speculated that Irx4 can negatively influence hematopoietic differentiation by forming 
an inhibitory complex with RXR and vitamin D3 which are important for 
hematopoietic differentiation; this inhibitory effect on hematopoietic differentiation 
would in turn potentiate cardiac differentiation, explaining the present observed effect 
of overexpression of Irx4 on general cardiac differentiation. 
In the future, more experiments will be added in order to generate more convincing 
data. Moreover, quantitation of the amount of cardiac cells (e.g. by immunostaining 
followed by flow cytometry) generated from overexpression of Irx4 will also be 
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needed. In addition, non-cardiac genes expression (e.g. genes in the hematopoietic 
lineage) will be also taken into consideration to see if overexpression of Irx4 favors 
only cardiac differentiation and/or whether suppression of differentiation into other 
lineage(s) would be observed. 
4.2 Role of Kv channels in maintaining the chacteristics of mESCs 
4.2.1 Inhibition of Ky channels led to a redistribution of the proportion of cells in 
different phases of the cell cycle: importance of Ky channels in cell cycle 
progression in native ESCs 
Previous study from my group shown that blockade of Ky channels decreased mESCs 
proliferation and led to a redistribution of proportion of cells in cell cycle: there was 
an increase in proportion of cells in GQ/GI phase and decrease in proportion of cells in 
S phase upon Ky channel blockade. Since blockade of Ky channels by TEA+ led to 
depolarization (data not shown), and mESCs were prevented from entering the S 
phase of the cell cycle and arrested cells in GQ/GI phase, this suggests 
hyperpolarization may be necessary for mESCs to progress from GQ/GI phase to S 
phase. Previous study has shown that Kv currents were recorded in mESCs (Wang et 
al., 2005). Kv channels are formed by homo- or heterotetramers of four Ky channel 
subunits. A number of Ky channel subunit mRNAs are found expressed in 
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undifferentiated ESCs (Wang et al., 2005). In the present investigation, the expression 
of Kv channel isoforms Kvl.2, Kvl.6 and BK at mRNA level was found to be 
downregulated in GQ/GI -synchronized mESCs when compared with that of S-phase 
synchronized mESCs. Since Ky channels are main determinants of membrane 
potential, down-regulation of KV channel expression in GQ/GI phase suggests a more 
depolarized membrane potential in GQ/GI when compared with that of S phase. In 
support of these functional and molecular findings, membrane potential measurement 
suggests that membrane potential changes during cell cycle progression with GQ/GI 
phase being more depolarized while S phase being more hyperpolarized. 
ESCs are rapidly dividing cells. ESCs are known to have unusual cell cycle when 
compared with other somatic cells (Fujii-Yamamoto et al., 2005; Jirmanova et al., 
2002; Kapur et al., 2007; Liu et al , 2007; White & Dalton, 2005). ESCs have a very 
short Gi phase, meaning that ESCs re-enter the S-phase very shortly after exit from 
M-phase. ESCs spend more than half of time in S-phase before entering the G2 phase. 
In contrast to somatic cells in which there are rhythmic changes of cydins' 
expressions and cyclin-dependent kinases (CDKs)' activities, most of these regulators 
are present at relatively stable level throughout ESC cell cycle (Fujii-Yamamoto et al., 
2005; Jirmanova et al., 2002). Moreover, ESCs are less reliant on exogenous growth 
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factors and do not quiescence on growth factor withdrawal (Savatier et al., 1996; 
Schratt et al., 2001). These previous findings suggested that ESCs have atypical cell 
cycle control which can attribute to their unique self-renewal characteristic. The 
present investigation adds additional information to how ESCs control their cell cycle: 
hyperpolarization is required for ESCs to progress from GQ/GI phase to S phase. 
The hyperpolarization that is required for Gi-to-S transition could influence calcium 
homeostasis that is involved in cell cycle progression process. This hyperpolarization 
could influence the gating of voltage-gated calcium channels. Alternatively, 
hyperpolarization could also increase the driving force for calcium influx through 
non-voltage-gated calcium channels. Further investigation is needed to determine 
whether the calcium signaling is affected by this Gi-to-S hyperpolarization. 
On the other hand, application of Kv channel blocker in other cell types may lead to an 
increase in cell volume and therefore a decrease in proliferation as shown in other 
study (Rouzaire-Dubois & Dubois，1998). It is suggested that cell volume changes 
may alter the concentration of cellular components involved in the expression or 
activity of cell cycle-regulating proteins (Renaudo et al., 2004). However, previous 
studies showed that in mESCs, there is no change in the expressions of cyclins or the 
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activities of CDKs that are important for the progression of mESCs from Gi phase to 
S phase (Fujii-Yamamoto et al., 2005; Jirmanova et al., 2002). It is therefore unlikely 
that Kv channel functions to change in cydins' expressions and CDKs' activities in 
native mESCs. In addition, in the present investigation, an increase in the size of 
mESCs after TEA+ treatment was not detected by microscopic investigation and flow 
cytometry; therefore, it appears unlikely that Ky channel affects mESC cell cycle 
progression by increasing cell volume. 
4.2.2 Inhibition of Ky channels led to a loss of pluripotency at molecular and 
functional levels: importance of Ky channels in the fate determination of mESCs 
The attenuation of mESC proliferation and the redistribution of cells in different 
phases of the cell cycle by Kv channel blockade were found not to be attributed to the 
change in apoptotic processes in the present study. Instead, inhibition of Kv channels 
by TEA+ resulted in a change in the expression of gem layer markers, suggesting a 
loss of pluripotency and hence the initiation of differentiation. There was an increase 
in expression of germ layer markers HNFlp, eHand, Nodal and Mixll, but not Soxl, 
Brachyury T (T) and Cdx2 upon Ky channel blockade. 
It is well-known that transforming growth factor beta (TGF(3) signaling pathway plays 
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fundamental roles in the development and physiology of developing embryo. Nodal, 
one of the superfamily ligands of TGFp signaling pathway, was previously shown to 
be responsible for inducing mesendoderm，the precursor of the definitive mesodermal 
and endodermal lineages during gastrulation (reviewed in (Schier, 2003)). In addition, 
Nodal was found to inhibit the differentiation along neuroectodermal pathway in vitro 
both in mESCs and hESCs (Smith et al., 2008; Vallier et al., 2004; Watanabe et al., 
2005). For instant, overexpression of nodal inhibitor in hESCs was found to lead to an 
increased expression of neuroectoderm marker Soxl (Smith et al., 2008). Consistently, 
Nodal—'— embryos have enhanced neuroectoderm differentiation, with an absence of 
mesendoderm differentiation (Camus et al., 2006). Therefore, Nodal signaling 
involves in both controlling mesendoderm differentiation, as well as in preventing 
cells from differentiating into neuroectodermal lineage. In our present investigation, 
blocking Ky channels increased Nodal expression. In addition, mesodermal marker 
Mixll and endodermal marker HNFlp were found to increase in expression while 
neural precursor marker Soxl was found to decrease in expression. This suggests that 
Kv channel blockade in ESCs may favor differentiation into mesendoderm but not 
neuroectoderm. 
It is worthwhile to note that markers from the same germ layer do not necessarily end 
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up with the same order of expression. eHand (trophectoderm) and Mixll (mesoderm) 
were up-regulated while Cdx2 (trophectoderm) and T (mesoderm) were 
down-regulated or even undetectable in TEA+-treated groups. Studies in interaction 
among the germ layer markers under investigation may help us gain some insights 
into this. Previous study showed that TGFp could induce the down-regulation of 
trophectoderm marker Cdx2 (Selesniemi et al., 2005). This may help reason why 
Cdx2 was down-regulated in TEA+-treated groups at the time point when Nodal was 
up-regulated. On the other hand, there was finding suggested that Mixll acted as the 
negative regulator of T (Izumi et al., 2007). In that study, when ESCs were put under 
condition that favors mesodermal differentiation, T expression decreased after day 3 
of differentiation when mixll expression increased. In addition, knockdown of Mixll 
resulted in the enhancement of T expression while overexpression of Mixll led to a 
suppressed T expression level (Izumi et al , 2007). This may help explain why Mixll 
increased while T decreased as observed in TEA+-treated group. Taken together, from 
the present investigation, Ky channels in undifferentiated state may function to 
suppress initiation of differentiation to mesendoderm and trophectoderm. 
Consistent with the loss of pluripotency as assessed by molecular markers, when 
TEA+-pre-treated mESCs were subjected to differentiation, EBs formed were much 
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smaller than those differentiated from control mESCs as assessed by two different 
differentiation methods. This suggests that Ky channel blockade in undifferentiated 
state would lead to an impaired ability of mESCs to differentiate, and shows the 
importance of Ky channel in maintaining the differentiation potentials of mESCs at 
functional level. 
4.3 Insights from the present investigation on the future uses of ESCs 
Due to the various insufficiencies of current treatments of MI, scientists are eager to 
find new sources of treatment that can overcome the shortcomings of current 
treatments and are in sufficient amounts. Recent findings indicate that ESC-CMs are 
genuine cardiac cells showing cardiac characteristics at molecular, 
electrophysiological and functional levels. However, the amount of ESC-CMs 
generated during differentiation was low and impure. Our findings at this stage 
showed that overexpression of Irx4 potentially resulted in a general increase in cardiac 
structural genes expression, this may help to overcome the shortcomings mentioned. 
On the other hand, the ways to control stem cell behavior has also been a crucial 
aspect of developmental biology and regenerative medicine. Teratoma formation has 
been one of the obstacles in the therapeutic use of embryonic stem cell derivatives. 
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Lessons from a number of mESCs and human ESCs studies indicated a risk of tumor 
formation after transplantation of non-purified cells (Behfar et al., 2007; Leor et al , 
2007; Nussbaum et al., 2007; Swijnenburg et al , 2005). This is presumably due to the 
presence of transplanted undifferentiated cells (which are present in the non-purified 
differentiation culture) which can proliferate indefinitely and thereby generate tumors. 
Studies have shown that inhibition of potassium channels reduced cell proliferation in 
various kinds of cancers like breast cancer (Wonderlin & Strobl, 1996), colon cancer 
[(Lastraioli et al., 2004)], melanoma (Wonderlin & Strobl, 1996), neuroblastoma 
(Wonderlin & Strobl, 1996) and prostate cancer (Skryma et al., 1997). Therefore, our 
finding on the role of Ky channels in ESCs may help to gain some insights into 
possible strategies of controlling the proliferation of undifferentiated ESCs (e.g. by 
target inhibition of distinct Ky channel isoforms that are shown to have expression 
changes during cell cycle progression, any undesirable cell proliferation may be 
inhibited) and therefore to facilitate therapeutic use of ESCs. 
In addition, the present study shows that the function of Kv channels would determine 
the fate of ESCs, that is, the decision of whether ESCs go through the cell cycle 
self-renewal process or whether ESCs go to the differentiation pathway. Therefore, in 
the future, directed differentiation of ESCs may be enhanced by adjusting an 
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appropriate activity of Kv channels or by adjusting a suitable membrane potential to 
favor ESC differentiation. 
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CONCLUSION 
In summary, overexpression of Irx4 was showed to possess the potential to increase 
the cardiac structural genes expression. Although the results are still preliminary, our 
findings at this stage may help lessen current hurdles in using ESC-CMs as 
therapeutic treatment by improving the yield of cardiac differentiation. 
On the other hand, Ky channels are key determinants of the ESCs to maintain their 
two unique characteristics: self-renewal and pluripotency. Previous study in our group 
showed that inhibition of Ky channels decreased mESC proliferation and led to the 
increase in proportion of cells in GQ/GI phase and a decrease in proportion of cells in 
S phase. In the present investigation, we further showed that this attenuation of 
increase in cell number was not due to apoptosis. Instead, it was due to loss of 
pluripotency and thereby differentiation: upon Kv channel blockade, there was a loss 
of pluripotency as demonstrated at molecular and functional levels. Kv channels may 
mediate their effects through their roles in maintaining an appropriate membrane 
potential for ESCs either to progress through the cell cycle in undifferentiated state or 
to differentiate. Consistently, mESCs at S phase were found to be more 
hyperpolarized than mESCs at GQ/GI phase，suggesting a change in membrane 
potential may be necessary for mESCs to progress through cell cycle in 
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undifferentiated state. This study shall not only provide interesting information about 
the biology of ESCs, this may also provide insights into the future applications of 
ESCs such as the possible strategies of eliminating tumor formation from ESC 
transplantation or enhancing ESC differentiation. 
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